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Psychotic disorder
The terms psychotic disorder or schizophrenia are often used interchangeably, 
whereas the latter is generally regarded as the more severe outcome on a psychosis 
continuum, with a lifetime prevalence of around 0.5-1.0% in the general population. 
Psychotic symptoms may occur in episodes or follow a more semi-continuous course 
and comprise hallucinations and delusions, frequently accompanied by affective, 
behavioural (avolition) and cognitive symptoms 1. Symptoms need to be treated 
expeditiously, since a longer duration of untreated psychosis (DUP) is significantly 
associated with a worse symptomatic outcome, a lower risk to achieve complete 
remission, and a decrease in social functioning 2. If diagnosed in time and treated with 
antipsychotic medication, symptomatic remission rates are 50-78%. Importantly, non-
pharmacological therapies play a central role in the treatment of psychotic disorder. 
Recovery (including good social and work functioning) rates still lag behind 3, and 
stress the importance of non-pharmacological ingredients even more.
The psychosis continuum
Psychotic experiences are a common phenomenon ranging from subclinical symptoms 
in the general population (especially in young adults, fluctuating in time and severity, 
rarely inducing nuisance) with a lifetime prevalence of 10-20%, to clinically disturbing 
symptoms or complaints (lifetime prevalence of 2-3%) 4. Most of the brief or minor 
(pre)psychotic symptoms in adolescence never transgress to the clinical disorder 
and disappear without a need for care 5. The prediction about who will make the 
conversion to psychosis is a challenge, as the prodromal phase appears to be rather 
non-specific, with a broader spectrum of symptoms, including anxiety and depressive 
symptoms 6. For this purpose, the so-called at-risk-mental state (ARMS) or ultra-high 
risk (UHR) criteria were defined as either: i) the presence of attenuated (subthreshold) 
psychotic symptoms, ii) a history of brief self limited psychotic symptoms, or iii) presu-
med genetic vulnerability to psychosis, in combination with persistent low functioning 
7. Recent studies have shown 12-month transition rates of 10-15%, and around 76% 
of the UHR subjects will not experience a psychotic episode during follow-up 8, 9. 
Once a psychotic episode has emerged, a proportion of individuals with the broader 
psychotic phenotype will attain good clinical and functional outcome, whereas the 
proportion of patients with the more narrowly defined phenotype (schizophrenia) 
who meet the recovery criteria, is only 13.5% and has not improved over the years 
10. Self-stigma, inducing lowered self-esteem and self-efficacy as well as social stigma, 
causing reduced access to employment and depleted social networks, may hamper 
recovery and functional remission11.
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Etiology
Genetic risk factors
The exact pathophysiology for schizophrenia is still unknown. Genetic contribution 
for the individual’s risk for schizophrenia is estimated to be high, around 64-81%. 
Candidate genes that have been described include the neuregulin1-tyrosine kinase 
receptor ErbB4 (NRG1-ErbB4), involved in the cortico-cortical myelination process 
during neurodevelopment 13, the brain-derived neurotropic factor (BDNF) Val66Met 
variant, implicated in neuronal growth and brain plasticity, and the Catechol-O-methyl 
transferase (COMT) Val158met single nucleotide polymorphism, which has been as-
sociated with the inactivation of extra-neuronal dopamine 14. A recent multi-stage 
genome-wide association study (GWAS) for schizophrenia identified 108 loci that met 
genome-wide significance. Associations at DRD2 and genes involved in glutamatergic 
neurotransmission comply with the leading pathophysiological (dopamine, glutamate) 
hypotheses 12. Indeed, the dopamine hypothesis of psychosis is still the most prevai-
ling one, suggesting that presynaptic striatal hyperdopaminergia is the final common 
pathway through which multiple environmental and genetic risk factors exert their 
effects. Within this theory, abnormal release of dopamine leads to an aberrant as-
signment of salience to otherwise neutral stimuli. This model may also explain the 
so-called negative symptoms of neglect and withdrawal, as this hyperdopaminergic 
state overrules dopaminergic reward signals to normal stimuli, resulting in reduced 
motivational drive 15.
Environmental risk factors
The etiology of schizophrenia cannot be fully attributed to a genetic cause. Twin stu-
dies have shown that approximately 80% of the phenotypic variance may be explained 
by genetic variation 16. Genetic risk variants may interact with environmental factors 
such as obstetric complications 17, 18, exposure to childhood trauma 19, adolescent 
cannabis use 20, 21 and growing up in an urban environment 22, 23. Some of these risk 
factors are supposed to cause increased stress at a vulnerable age period (childhood, 
young adulthood) during the brains’ most critical developmental phase. Repeated 
exposure to these stressors may lead to altered stress-signalling pathways resulting 
in disturbed neuronal responsiveness and symptoms of profound prefrontal cortical 
dysfunction 24, as well as sensitization of mesolimbic dopamine neurons 25, inducing 
psychotic symptoms. In addition, associations between childhood trauma and volume 
reductions in the corpus callosum 26 and hippocampus 27 have been reported, as well 
as impaired synaptic plasticity in relation to cannabis use 28. In the above-mentioned 
studies, various neuroimaging techniques were used to link neuroanatomical abnor-
malities with psychological or biological models of psychotic disorder.
General introduction
13
1
Structural brain imaging in psychotic disorder
Magnetic resonance imaging (MRI) was introduced in the early 1980s as the successor 
of the X-ray computed tomography (CT). The CT scan was one of the earliest imaging 
techniques applied to psychiatric patients, providing the most replicated finding in 
patients with schizophrenia; enlargement of the lateral ventricles 29. MRI research can 
be categorized in structural and functional neuroimaging. The focus in this thesis is 
primarily on structural imaging, as this is currently the best method for examining the 
effects of psychiatric disorders on brain volume and morphometry (size, shape) over 
time 30. Since the first MRI study of schizophrenia in 1984 by Smith and colleagues 
(1984) 31, numerous structural imaging results have been published. The main volu-
metric findings in patients with schizophrenia compared to healthy controls are: i) 
similar brain size, ii) enlarged lateral ventricles, iii) grey matter (GM) and white matter 
(WM) volume reductions in the (left) medial temporal lobe (hippocampus), the (left) 
superior temporal gyrus and less consistent abnormalities in the parietal lobe and 
subcortical regions (basal ganglia, cerebellum, thalamus and corpus callosum) 32, 33. 
Studies measuring cortical thickness, a proxy measure of cyto-architectural integrity, 
have found widespread cortical thinning in mainly fronto-temporo-parietal regions in 
patients with chronic 34 and subacute 35 psychotic disorder, as well as in patients with 
first-episode psychosis 36 compared to healthy controls.
The exact timing of onset and course of the brain alterations in schizophrenia is un-
resolved. Schizophrenia has been described as a neurodevelopmental disorder with 
brain alterations caused by susceptibility genes and environmental factors occurring 
in early life before disease onset 37, as a progressive or a neurodegenerative disorder 
with brain alterations emerging around disease onset and worsening over time 38, 
and as a combination of both. Evidence for a neurodevelopmental origin have been 
obtained from studies reporting structural brain volume differences 39, for instance 
in the anterior cingulate gyrus 40, in clinical high risk samples before the onset of 
psychotic symptoms. Progressive brain alterations were found in a large systematic 
review and meta-analysis by Olabi and colleagues (2011), showing statistically signifi-
cant progressive reductions in whole brain, whole brain GM and frontal lobe volumes, 
as well as frontal, parietal, and temporal lobe white matter decrements and lateral 
ventricular volume enlargement over time in patients with schizophrenia compared 
to healthy controls 41. These results seem to support both models, suggesting that 
the cerebral alterations in psychosis involve an on-going process of genetic and en-
vironmental as well as epistatic and epigenetic interactions 37, 42, but also illness- or 
treatment related factors. As stated before, multiple brain areas have been associated 
with schizophrenia, pointing to altered networks / neuronal connectivity, as demon-
strated in several neurophysiological and functional imaging studies 43, 44. The dyscon-
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nectivity hypothesis as formulated by Friston (1998) implies that the core pathology 
of schizophrenia is the result of faults in abnormal epigenetic, activity- and experience 
dependent N-methyl-D-aspartate receptor (NMDAR) mediated synaptic plasticity by 
modulatory neurotransmitters like dopamine. This aberrant wiring may cause long-
term changes in connection strength of functionally specialized interconnected brain 
systems, leading to a failure in self-monitoring and eventually the characteristic psy-
chotic symptoms 45, 46. A structural imaging modality named diffusion tensor imaging 
(DTI) and functional MRI (fMRI) are commonly used to study respectively structural 
and functional inter-regional connectivity.
Diffusion tensor imaging
For the last twenty years, DTI has been used to investigate neurological disorders, 
especially in patients with acute stroke. As an indirect measure for the connectivity 
of white matter axons in the central nervous system, it has also rapidly become a 
standard for disorders that are associated with white matter abnormalities. DTI uses 
the principle of molecular diffusion, a random translational motion of molecules (also 
called Brownian motion or isotropic diffusion, if not hindered by any boundaries). Ho-
wever, in the brain diffusion patterns are different, as water molecules bounce, cross 
and interact with various tissue components as cell membranes, and (myelinated) 
axonal fibres. Water molecules tend to move along the axis of the neuron, parallel to 
the direction of the fibres, which is called anisotropic diffusion. This diffusion data can 
be analysed for information on tissue microstructure and fibre architecture, using the 
diffusion tensor in three different ways and calculating the: i) mean diffusivity, ii) frac-
tional anisotropy (FA), relating to the presence and coherence of oriented structures 
and iii) main direction of diffusivities 47, 48. In this thesis, FA will be the most discussed 
diffusion coefficient, set out between 0 and 1; high in white matter, low in grey mat-
ter and close to zero in cerebrospinal fluid. Regional FA changes may point to white 
matter abnormalities, but do not specify the nature of the change. WM alterations 
may be multi-causal, referring to a distorted demyelination process, fibre reduction 
or incoherence, or differences in the proportion of axonal, oligodendrocyte and glial 
cellular components 49. In addition, FA is not a steady value, but follows a tract-specific 
curvilinear maturation pattern, with an increase of FA from newborn to adolescence, 
decelerated maturation until mid-adulthood and then a gradual decline at old age 50.
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Diffusion studies in psychotic disorder
Patient – control differences
Over three hundred diffusion studies have been performed since the late 1990s with 
patients with a psychotic disorder in various stages of the illness. Numerous cross-
sectional studies reported widespread white matter alterations in patient samples 
compared to healthy controls, whereby the findings in first-episode patients seem less 
robust than in later stage patients. Several WM regions seem to be affected, whereas 
the most frequently studied and mentioned major WM tract is the corpus callosum, 
followed by the arcuate fasciculus, fronto-occipital fasciculus, but also more broader 
defined frontal, temporal, and parietal regions 51. A meta-analysis by Ellison-Wright 
& Bullmore (2009), based on 15 studies, showed two regions with significant FA re-
ductions: one cluster in the left frontal deep white matter (anterior thalamic radiation 
and corticobulbar tracts, inter-hemispheric fibres running through the genu of the 
corpus callosum, the inferior fronto-occipital fasciculus and the cingulum bundle) and 
the left temporal deep white matter (interhemispheric fibers running through the 
splenium of the corpus callosum, the inferior fronto-occipital fasciculus, the inferior 
longitudinal fasciculus and the fornix/stria terminalis) 52. Differences in methodology 
and sample characteristics (e.g. clinical heterogeneity, smoking history, exercise, body 
weight, lipid levels) as well as systematic confounders (motion artefacts, medication) 
may explain the varying patterns between studies 53.
Overall, psychotic disorder has been related to widespread FA decreases in the lite-
rature. In contrast, some studies reported FA increases in fibres connecting temporal 
regions (such as in the left medial temporal lobe) in clinical high risk subjects who 
made the transition to psychosis compared to the non-transition group 54. The same 
applies to the arcuate fasciculus 55, 56 and superior longitudinal fasciculus 57, in patients 
with psychotic disorder experiencing more severe hallucinations.
Notwithstanding the fact that associations between WM alterations and clinical 
symptoms have yielded inconclusive results (showing significant associations in half 
of the studies), positive associations between FA and positive symptoms (e.g. inferior 
longitudinal fasciculus, cingulum bundle) and negative associations between FA and 
negative symptoms (uncinate fasciculus, superior longitudinal fasciculus) have been 
reported 58.
Antipsychotic medication
The potential influence of illness-related factors in patients with psychotic disorder, 
such as a disadvantageous life style and health issues (e.g. lack of exercise, social 
deprivation, smoking), on brain tissue is not well understood. The same applies to 
the potential effect of antipsychotic (AP) medication on brain structure 59. Here, it 
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has to be kept in mind that accounting for AP use in imaging studies with a patient 
– control design is complex, as it may imply controlling for patient-status. In recent 
years, increasing attention has been given to the examination of AP effects on WM 
integrity in cross-sectional and longitudinal studies with contrasting results. A nega-
tive (trend) significant association between FA and duration of AP use in certain brain 
regions (arcuate fasciculus, superior longitudinal fasciculus) 58, FA reductions within 
the parietal and occipital WM after 12 weeks of AP treatment 60 as well as FA increases 
in widespread brain regions after 12 weeks op clozapine treatment 61.
As microstructural WM alterations can also be detected in medication-naïve patients 
62, 63, AP use is most likely one of the contributing factors to brain alteration. Besides 
the clinical high-risk approach, another way to contribute to the medication debate is 
to investigate WM structure in individuals with a higher-than-average genetic risk for 
psychosis (e.g. unaffected relatives of patients with psychotic disorder).
Intermediate phenotype
Examining brain alterations in unaffected relatives of patients with a psychotic disorder 
is also a precondition for identifying a diffusion intermediate phenotype. An interme-
diate phenotype is a measurable biological marker, in this case a microstructural WM 
alteration, related to the underlying disease mechanism with a genetic foundation. 
A candidate intermediate phenotype should at least e.g. be heritable, be present in 
absence of certain symptoms and be present in unaffected relatives of patients at a 
higher rate than the general population 64. A recent qualitative review by Arat and 
colleagues (2015) provided an overview of 13 studies measuring diffusion parameters 
in unaffected siblings of patients with schizophrenia compared to healthy controls. 
Although based on a relatively small number of studies with varying methodological 
and sample characteristics, it was concluded that most studies show WM abnormali-
ties in unaffected siblings in similar regions (e.g. frontal and temporal WM tracts) as 
identified in patients with a psychotic disorder. Especially in the genu of the corpus 
callosum significant differences in diffusion parameters were found 65, 66, leading the 
authors to state that disrupted WM integrity in this region may be an intermediate 
phenotype for schizophrenia 67.
FA course over time
Conform the volumetric findings, neurodevelopmental decreased WM integrity in 
clinical high-risk populations 68, 69, as well as post-onset progression of widespread 
WM alterations in patients with late stage psychotic disorder 70 has been reported. 
Longitudinal diffusion studies are scarce and have focused on changes in WM inte-
grity during transition from UHR status to first-episode psychosis status 71, or before 
and after short periods of AP treatment in first-episode 72 and late stage patients 73. 
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Only one study examined the course of WM development over a longer period of 
time in patients with chronic schizophrenia (n=49) and found a stronger FA decline 
over 4 years in patients compared to controls in the left anterior cingulate and in the 
bilateral orbitofrontal region 74, suggesting a differential WM integrity course over 
time. Clearly, there is a gap in the literature with regard to longitudinal studies of 
microstructural WM alterations over the course of illness.
Genes, environment and microstructural white matter
WM volume in healthy twin-samples has shown to be a highly heritable phenotype. 
It is estimated that genetic factors account for around 85-88% of the individual dif-
ference in whole brain WM volume 75, 76. White matter FA shows moderate to high 
heritability (0.4 – 0.7) depending on the tract, and with the exception of the cortico-
spinal tract (lower values). The heritability indices are slightly higher during neonatal 
period and childhood 77, 78, but on the whole seem rather stable. Recently, Bohlken 
and colleagues (2016) reported that 83.4% of the association between global FA 
and schizophrenia liability can be explained by common genes 79. In other words, 
the white matter alterations can, to a great extent, be seen as a genetic liability to 
schizophrenia.
Candidate genes for WM heritability (in health and mental disorder) that have been 
reported indeed are involved in oligodendrocyte, myelin and axonal development and 
maintenance. Over the years, the neuregulin1-tyrosine kinase receptor ErbB4 (NRG1-
ErbB4) gene system (because of its apparent role in cortico-cortical myelination 
process during neurodevelopment 80), the disrupted-in-schizophrenia 1 (DISC1) gene 
81, and a val66met BDNF polymorphism 82 have been mentioned in this respect. In 
more recent imaging-genetic studies, the focus has shifted to the GWAS risk genes for 
schizophrenia and their impact on brain structure. For example, associations between 
white matter integrity and ANK3 and ZNF804A 83 were reported. In healthy young 
adults, a NTRK3 gene variant associated with WM integrity of the corpus callosum 
has been described 84.
In contrast to the ample number of genetic studies on the etiology of WM pathology 
in psychotic disorder, studies examining and integrating environmental risk factors in 
a design are scarce. There are some studies examining the effect of cannabis expo-
sure on WM structure in patients with schizophrenia, showing FA increases as well as 
decreases in cannabis using versus non-using patients 51, 85. The effect of childhood 
trauma exposure on microstructural WM development has only been investigated in 
non-psychotic samples. For example, reduced FA in the inferior longitudinal fasciculus 
of the left lateral occipital lobe in twenty young adults witnessing domestic violence in 
childhood 86, and reduced FA in the medial and posterior corpus callosum in trauma-
tized children with posttraumatic stress disorder 87 have been reported. Except for a 
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few volumetric studies, there has been no investigation on associations of obstetrical 
complications and WM integrity and developmental urbanicity and WM integrity. A 
study by Cannon and colleagues (2002) found that foetal hypoxia was not related to 
WM volume, but predicted reduced GM volume and increased CSF bilaterally throu-
ghout the cortex, especially in the temporal lobe, in patients with schizophrenia and 
their unaffected siblings compared to healthy controls 88. A voxel-based morphometry 
study reported an inverse correlation between early-life urbanicity and GM volume in 
the right dorsolateral prefrontal cortex and a negative correlation with the perigenual 
anterior cingulate cortex GM volume in healthy males 89. Thus, there is room for in-
tegrating the environment/context in diffusion studies in order to better understand 
cerebral microstructural white matter alterations in the psychosis syndrome.
Outline and aim of the thesis
The aim of this thesis is to examine whole-brain white matter integrity, cross-sectio-
nally as well as a longitudinally, in patients with a psychotic disorder with a relatively 
short-moderate illness duration, in individuals at higher-than-average genetic risk 
(unaffected siblings of patients with a psychotic disorder) and in individuals at average 
genetic risk (healthy controls). Therefore, diffusion tensor imaging scans were col-
lected to: i) determine whether a microstructural WM endophenotype for psychotic 
disorder can be identified, ii) investigate the pattern/course of microstructural WM 
connectivity alterations over time, iii) examine whether microstructural WM con-
nectivity alterations can be appraised as the outcome of differential sensitivity to 
environmental risk factors (i.e. cannabis use and childhood trauma).
Study design
Participants were recruited in the context of a large multi-site (the academic psychia-
tric centres of Amsterdam, Groningen, Maastricht, Utrecht and their affiliated mental 
health care institutions) longitudinal, observational, cohort study: Genetic Risk and 
Outcome of Psychosis (G.R.O.U.P.) in the Netherlands. This study was held from April 
2004 till December 2013, examining the vulnerability and protective factors for psy-
chotic disorder by assessing genetic, biological, psychological and social factors. Du-
ring the baseline measurement, data of 1120 patients with a non-affective psychotic 
disorder, 1057 of their healthy siblings, 919 of their parents and 590 unrelated healthy 
controls have been collected, including symptomatology measures, various risk and 
protective factors, blood and urine samples (DNA analysis and drug screenings) 90. In 
addition, structural (including diffusion imaging) and functional MRI scans were ob-
tained locally at Maastricht University using a 3T Siemens scanner. Participants from 
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a selected representative geographical area around Maastricht and in Belgium were 
included. At baseline, the total MRI sample comprised 274 participants: 89 patients 
with a psychotic disorder, 98 unaffected siblings and 87 healthy controls. At follow 
up (on average three years later), roughly two-third of this sample was scanned for a 
second time. Studies described in this thesis were conducted with this G.R.O.U.P. MRI 
add-on sample.
Thesis content
The search for a WM intermediate phenotype is discussed in chapter 2. To date, 
numerous DTI studies in patients with psychotic disorder have undisputedly shown 
a decrease in FA in fronto-temporal and fronto-occipital connections, indicative of 
white matter integrity loss. Fewer DTI studies, with smaller sample sizes, have been 
performed on individuals at higher-than-average genetic risk for psychotic disorder. 
Nonetheless, the available evidence suggests that white matter alterations may also 
be present in first-degree relatives without psychotic symptoms, pointing to a pos-
sible WM intermediate phenotype. Group differences in white matter integrity were 
analysed, using a whole-brain DTI approach to examine patients with a psychotic 
disorder, their non-psychotic siblings, and a healthy control group (n=258). Based 
on previous literature, we hypothesized that patients with psychotic disorder would 
show reduced white matter integrity compared to healthy controls, particularly in 
the corpus callosum, fronto-temporal, and fronto-parietal connections, with siblings 
showing a intermediate pattern of alterations. Confounding by medication or illicit 
drugs and sex differences were investigated as part of the main analyses.
Chapter 3 addresses the topic of white matter progression over time in patients with 
a psychotic disorder as well as their healthy siblings. Evidence for WM alterations 
in clinical high-risk populations and first episode patients derive mainly from cross-
sectional DTI studies. Longitudinal diffusion studies are scarce and, as a consequence, 
the clinical evidence for post-onset microstructural with matter progression is mini-
mal. The aim of this study was to investigate longitudinally the course of microstruc-
tural WM change over time in a family study design. Individuals were scanned twice 
(n=159) with an average of a 3-year interval. We hypothesized that in individuals with 
(liability for) psychosis, whole-brain FA decrease would be stronger and earlier than 
expected by age as compared to controls, indicating differential trajectories over time 
as a function of level of psychosis liability.
The same longitudinal design was used to examine the impact of environmental risk 
factors of psychotic disorder on white matter alterations. That study is presented in 
chapter 4. Although epidemiological studies have pointed to environmental exposures 
such as pre- or postnatal birth complications, cannabis use, developmental trauma 
and urbanicity as risk factors for psychotic disorder, their association with cerebral 
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alteration has hardly been studied. In this study we investigated whether microstruc-
tural white matter alterations in individuals with (liability for) psychotic disorder were 
conditional on the exposure to cannabis or childhood trauma. More specifically, we 
hypothesized that individuals at increased genetic risk (patients and siblings) with 
higher exposure levels to cannabis and childhood trauma would show reduced white 
matter integrity at baseline and increased WM deterioration over time.
In chapter 5, the findings of this thesis are integrated and discussed in more detail, 
providing directions for future research.
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ABSTRACT
Background. There is evidence for microstructural white matter alterations in patients 
with psychotic disorder, suggesting altered interregional connectivity. Less is known 
about the presence and role of white matter alterations in well individuals at higher 
than average genetic risk for psychotic disorder.
Methods. 85 patients with psychotic disorder, 93 non-psychotic siblings of patients 
with psychotic disorder and 80 healthy controls underwent a diffusion tensor imaging 
(DTI) scanning protocol. In a whole brain voxel-based analysis using Tract Based Spatial 
Statistics (TBSS), fractional anisotropy (FA) values were compared between the three 
groups. Effects of antipsychotic medication and drug use were examined.
Results. The patients displayed significantly lower mean FA than the controls in the 
following regions: corpus callosum (genu, body, splenium), forceps major and minor, 
external capsule bilaterally, corona radiata (anterior, posterior) bilaterally, left supe-
rior corona radiata and posterior thalamic radiation bilaterally. Similar FA differences 
existed between the patients and the siblings; the siblings did not differ from the 
controls.
Conclusion. Profound microstructural white matter alterations were found in the 
corpus callosum and other tracti and fasciculi in the patients with psychotic disorder, 
but not in the siblings and the controls. These alterations may reflect brain pathology 
associated with the illness, illness-related environmental risk factors, or its treatment, 
rather than genetic risk.
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Introduction
There is growing evidence that cerebral vulnerability in schizophrenia may be media-
ted by altered connectivity between brain regions, rather than focal brain alterations. 
Indeed, neurophysiological and functional neuroimaging studies have demonstrated 
pathological functional connectivity 1-3. Dysconnectivity, in terms of impaired axonal 
mechanisms and/or abnormal control of synaptic plasticity, may form the core patho-
logy of schizophrenia 4, and may be based in structural alterations. In support of this, 
volumetric MRI studies have shown decreased white matter volumes of the frontal 
lobes and temporo-parietal regions and a decreased corpus callosum volume (genu 
and/or truncus) in patients with schizophrenia5-7. Since the late nineties, numerous DTI-
studies in patients with a diagnosis of schizophrenia have been published, showing a 
decrease in FA, indicative of white matter integrity loss, in several brain tracts, including 
the fronto-temporal connections, such as the arcuate fasciculus, anterior cingulum 
bundle, uncinate fasciculus 8-10 and fronto-occipital tracts 11, 12. A meta-analysis in 2009 
concluded that significant reductions were present in frontal deep white matter (genu 
corpus callosum, cingulum bundle, left anterior thalamic radiation, left corticobulbar 
tract and left inferior fronto-occipital fasciculus) and temporal deep white matter (sple-
nium corpus callosum, fornix/stria terminalis, left inferior longitudinal fasciculus and left 
inferior fronto-occipital fasciculus) 13. Although most, but not all studies 14-16 report FA 
decreases associated with schizophrenia, there is inconsistency regarding the location 
of the affected brain regions, which, in part, may be related to differences in scanning 
protocol, study design (eg. characteristics of the participants) and analytical techniques.
Structural dysconnectivity in patients with schizophrenia may reflect disease-related 
pathology, but may also represent expression of genetic risk for the disorder 17. Thus, 
volumetric MRI studies in first-degree relatives 18, 19 and twins 20 have shown indirect 
genetic effects on global grey and white matter volume reduction in schizophrenia. 
The number of DTI studies examining individuals at higher than average genetic risk for 
psychotic disorder is scant and sample sizes are, in general, small (number of high-risk 
individuals ranging from n=16 to n=34), except for one study 21. The available evidence 
suggests that white matter alterations may be present in first-degree relatives without 
symptoms 21-27. The results for so-called “ultra-high risk” samples with (pre)clinical 
symptoms are conflicting 28, which likely is related to lack of consistency in ultra-high 
risk sample enrichment procedures across studies 29 as well as to differences in brain 
regions studied and methodological approaches, precluding definite conclusions.
In the present large, DTI study (n=258), whole-brain, voxel-based analytic techniques 
were used to examine patients with a psychotic disorder (highest genetic risk group), 
non-psychotic siblings (higher than average genetic risk group) of patients with a psy-
chotic disorder, and healthy controls (average genetic risk group). We hypothesized 
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that the patients with psychotic disorder would show reduced white matter integrity 
compared to the healthy controls, particularly in the corpus callosum, fronto-tempo-
ral, and fronto-parietal connections, with the siblings showing a pattern of alterations 
of intermediate severity.
Methods
Participants
The patients were recruited from an on-going longitudinal MRI study in Maastricht, 
the Netherlands. In selected representative geographical areas in the Netherlands 
and Belgium, the patients were identified through representative clinicians providing 
health care for patients with psychotic disorder. The siblings were contacted through 
the participating patients. Mailings and advertisements were effectuated in local 
newspapers of the same geographical area in order to recruit control participants. 
The total sample consisted of 258 participants: 85 patients with a psychotic disorder, 
93 siblings without a psychotic disorder and 80 healthy controls. The sample included 
56 families, of which 35 families contributed one patient and one healthy sibling, 
three families contributed one patient and two healthy siblings, and one family contri-
buted one patient and three healthy siblings. One family contributed two patients, six 
families contributed two healthy siblings, and one family contributed three healthy 
siblings. In the control group, 9 families contributed two siblings. In addition, 44 
families contributed a single patient, 34 families contributed a single sibling, and 62 
families contributed a single control.
Inclusion criteria were: age range 16-50 years, a good command of Dutch language 
and for patients: a diagnosis of non-affective psychotic disorder with an illness du-
ration of <10 years. The siblings and the controls did not have a lifetime diagnosis 
of any non-affective psychotic disorder. In addition, the controls had no first-degree 
relative with a lifetime diagnosis of any psychotic disorder, assessed using the Family 
Interview for Genetic Studies (FIGS) 30.
Diagnosis was based on the Diagnostic and Statistical Manual of Mental Disorder-IV 
(DSM-IV) criteria 31, measured with the Comprehensive Assessment of Symptoms 
and History (CASH) interview 32. The patients were diagnosed as follows: schizophr-
enia (n=59), schizoaffective disorder (n=9), schizophreniform disorder (n=4), brief 
psychotic disorder (n=2), and psychotic disorder not otherwise specified (n=11). 
Psychopathology in the siblings and controls was also assessed and respectively 18 
and 12 participants had a history of a major depressive disorder. None of these met 
the criteria for a current depressive episode.
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All the participants were screened before MRI acquisition for the following exclusion 
criteria: brain injury with unconsciousness of greater than 1 h, meningitis or other 
neurological diseases with possible impact on brain structure or function, cardiac 
arrhythmia requiring medical treatment and severe claustrophobia. In addition, sub-
jects with metal corpora aliena were excluded from the study, as were women with 
intrauterine device status and (suspected) pregnancy.
The standing ethics committee approved the study protocol, and all the participants 
gave written informed consent in accordance with the committee’s guidelines.
Measures
Level of psychotic symptomatology at the time of scanning was assessed with the 
Positive and Negative Symptom Scale (PANSS) 33 in all three groups. The five factor 
model by van der Gaag and colleagues (2006), was used dividing the PANSS in positive 
symptoms, negative symptoms, disorganization symptoms, excitement and emotional 
distress 34. The scores of the individual items of the 5 symptom dimensions were sum-
med.
Educational level was defined as highest accomplished level of education. Handed-
ness was assessed using the Annett Handedness Scale 35.
In the patient group, antipsychotic (AP) medication use was determined by the 
patient’s report and verified with the treating consultant psychiatrist. Best estimate 
lifetime (cumulative) AP use was determined by multiplying the number of days of AP 
use with the corresponding haloperidol equivalents and summing these scores for all 
periods of AP use (including the exposure period between baseline assessment for 
the G.R.O.U.P. study and the moment of baseline MRI scanning), using the recently 
published converting formulas for AP dose equivalents described by Andreasen and 
colleagues 36.
Substance use was measured with the Composite International Diagnostic Interview 
(CIDI) sections B-J-L 37. Use of cannabis and other drugs was assessed as reported 
frequency of use during the last 12 months, as well as lifetime use. CIDI frequency 
data on lifetime cannabis and other drug use was available for respectively 250 parti-
cipants (3% missing data) and 256 participants (1% missing data).
Alcohol use was defined as the reported number of weekly consumptions during the 
last 12 months.
Image acquisition
Magnetic resonance imaging scans were obtained at Maastricht University, the Ne-
therlands, using an Allegra syngo MR A30 (Siemens, Erlangen, Germany) operating 
at 3.0 T. The following anatomical scan parameters were used: Modified Driven 
Equilibrium Fourier Transform (MDEFT) sequence; 176 slices, 1 mm isotropic voxel 
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size, echo time 2.4 ms, repetition time 7.92 ms, inversion time 910 ms, flip angle 
15°, total acquisition time 12 min 51 sec; Magnetization Prepared Rapid Acquisition 
Gradient-Echo (MPRAGE; Alzheimer’s Disease Neuroimaging Initiative) sequence 192 
slices, 1 mm isotropic voxel size, echo time 2.6 ms, repetition time 2250 ms, inversion 
time 900 ms, flip angle 9°, total acquisition time 7 min 23 s. The matrix size was 256 
× 256 and field of view was 256 × 256 mm2. The number of excitations was one. Two 
sequences were used because of a scanner update during data collection.
Microstructural anatomy was examined using diffusion tensor imaging with an echo-
planar-imaging sequence (field of view 230 × 230 mm2, TR 10800 ms, TE 84 ms, voxel size 
1.8 × 1.8 × 1.8 mm³, b-value 1000 s/mm², noise level 40, 85 slices, no overlap). As a result 
of the scanner update, two DTI sequences were used: one with 76 directions (of which 
4 T2-weighted (B0) and 72 diffusion-weighted (B)), and one with 81 directions (8×B0 and 
73×B). The proportion of scans with 76 directions was balanced between the groups (78% 
in the controls, 75% in the siblings and 69% in the patients (χ2 =1.52, P= 0.468), preventing 
any systematic bias. Total acquisition time of the DTI sequence was 15 min.
Diffusion tensor imaging analysis
Processing of DTI data was effectuated using tract-based spatial statistics (TBSS) v1.2 
in FSL 4.1.6 (FMRIB Analysis Group, Oxford, UK, http://www.fmrib.ox.ac.uk/analysis/
research/tbss). First, standard Siemens DICOM files were transformed into compres-
sed NIFTI format using a custom built in-house software named GIANT (General Image 
ANalysis Tools developed by EHBMG). Raw data were corrected for head movement 
and eddy currents invoked during scanning. The B0 volume was skull-stripped using 
FSL’s Brain Extraction Tool 38 and this served as a brain mask for all B volumes.
The next step was fitting a diffusion tensor model at each voxel using data output 
from the brain extraction, diffusion weighted data and gradient directions following 
a general linear model (FreeSurfer v4.5.0, http://surfer.nmr.mgh.harvard.edu). After 
tensor fitting the process continued working on FA volumes, eroding them slightly.
Nonlinear registration aligned each FA volume to 1 × 1 × 1 mm standard FMRIB58_FA 
space. The standard FMRIB58_FA contains a template derived from high-resolution 
images of 58 participants in a well-aligned population (both males and females ran-
ging between 20 and 50 years of age) 39.
After nonlinear transformation of the FA volumes into standard space, a mean FA ske-
leton from all the participants per group was derived. The mean FA skeleton follows 
the major white matter tracts in each individual participant (normalized in MNI152 
space) and provides a way to compare between (groups of) the participants. The final 
step of the processing was setting the FA threshold using visual inspection of the FA 
skeleton, in the present study at a level of 0.25, to include major white matter tracts 
while removing small peripheral tracts that would cause excess inter-participant vari-
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ability. In addition, this threshold setting avoided inclusion of regions that are likely to 
be composed of multiple tissue types or fiber orientations.
Statistical analyses
Voxel-wise statistical analysis was performed on the mean FA skeleton using a general 
linear model and applying FSL’s randomize (v2.1) permutation-testing script 40. The 
comparisons involved the statistical tests of group differences in FA, yielding a total of 
six contrasts: i) mean FA is lower (or higher) in the patients compared to the controls, ii) 
mean FA is lower (or higher) in the siblings compared to the controls, and iii) mean FA 
is lower (or higher) in the patients compared to the siblings. The a priori hypothesized 
confounding variables age, sex, handedness, level of education, lifetime cannabis use 
and lifetime other drug use were used in the statistical model. In addition to tests for 
regional group differences, stratified gender analyses were carried out.
In addition, associations between AP medication and FA were analyzed in two dif-
ferent ways. First, cumulative AP exposure was added as an additional covariate. 
Second, in the patients only, cumulative AP exposure was entered as independent 
(dummy) variable representing the distribution of scores divided by its tertiles (low, 
medium and high exposure) to examine the effect on FA within the patients.
Lastly, planned sensitivity analyses were performed excluding the siblings and con-
trols with a history of affective disorder.
For the main analysis permutation tests were performed using 50,000 permutations in 
order to reduce the margin of error to acceptable uncertainty levels (P=0.05±0.00195, 
ie. 3.9% of the nominal alpha). With regard to the additional analyses (effects of AP 
medication and gender, exclusion of affective disorder) 10,000 - 50,000 permutations 
were performed. The threshold free cluster enhancement (TFCE) option was enabled 
to find clusters without setting an initial cluster level 41. Statistical maps (thresholded 
at P<0.05) were used for assessing differences between groups (corrected for multiple 
comparisons).
The Johns Hopkins University International Consortium for Brain Mapping (JHU 
ICBM)-DTI-81 white-matter atlas labels 42 were used to label significant voxels and 
assign a specific tract name. If the voxels did not match with the JHU ICBM labels, 
they were identified using the JHU white-matter tractography atlas 43. A binary mask 
was created containing the significant clusters in order to extract FA values of the 
individual participants.
For visualization purposes (see Fig.1) and to extend the TBSS analyses, from all 38 JHU 
labeled white matter tracts, skeleton mean FA values were extracted and exported to 
Stata version 12 44. Regional group differences were tested with multilevel random 
regression procedures using the Stata XTREG command with adjustment for the a pri-
ori hypothesized confounding variables age, sex, handedness, and level of education.
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In addition, the data set was transformed from a wide to a long format, resulting in 
a hierarchically structured data set, with 38 regional FA measures (Level 1) nested in 
subjects (Level 2) who were part of the same families (Level 3). Because of the three-
level grouping structure of the data, compromising statistical independence of the 
observations, multilevel random regression models were fitted using the XTMIXED 
command in Stata with FA measures as the dependent variable and subject number 
and family number modelled as random effects. Mixed models contain both fixed and 
random effects, the fixed effects being analogous to standard regression coefficients 
(B).
Main effects of group and group × sex interactions in the model of FA were examined, 
as well as associations between cumulative AP dose and FA in the patient group. The 
same covariates were used as described above.
Results
Descriptive analyses
There were more women than men in the control group, whereas the opposite held 
for the patient group. The study comprised a relatively stable patient group as reflec-
ted by the low PANSS scores. The patients were more frequent cannabis- and other 
drug users than the siblings and controls (Table 1). At the time of scanning, seventy 
patients were receiving AP medication (second generation: n=67; first generation: 
n=3). The mean current dosage of AP medication in terms of standard haloperidol 
equivalents was 5.5 milligrams (mg) (SD = 4.6). Furthermore, 16 patients used antide-
pressants, 6 used benzodiazepines, 5 used anticonvulsants, and 2 used lithium. Three 
siblings and 3 control participants used antidepressants, and one control participant 
used benzodiazepines.
Whole-brain group differences in FA
Voxel-wise analysis in TBSS revealed significant differences in mean FA in two out of 
six comparisons, indicating that the patients had a lower mean FA than the controls 
and siblings. The number of voxels for each white matter tract with a significant hi-
gher FA (P <0.05) in the controls and siblings, compared to patients, were derived and 
shown in Table 2.
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Fig. 1. Two white matt er regions with a signifi cantly lower mean FA value in the pati ents vs. the 
controls (**body of the corpus callosum: B = -.016, P = 0.001, anterior corona radiata, left : B = 
-.013, P = 0.004) and in the pati ents vs. the siblings (*body of the corpus callosum: B = .013, P = 
0.002); controlled for age, sex, handedness, highest level of educati on.
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Fig. 2. Axial view of white matter regions, mainly the Corpus Callosum, in MNI 
space (x:89, y:107, z:98), where the patients have significant lower mean FA values 
compared to the controls (A,B,C) and the siblings (D,E,F). All results were controlled 
for age, sex, handedness, highest level of education, and additionally for cannabis use 
(B, E) and cannabis and other drug use (C, F). Statistical maps were thresholded at P 
< 0.05, with the colormap reflecting the P-values, ranging from 0.05 (red) to 0.00 
(yellow). 
 
  
Fig. 2. Axial view of white matt er regions, mainly the Corpus Callosum, in MNI space (x:89, 
y:107, z:98), where the pati ents have signifi cant lower mean FA values compared to the controls 
(A,B,C) and the siblings (D,E,F). All results were controlled for age, sex, handedness, highest level 
of educati on, and additi onally for cannabis use (B, E) and cannabis and other drug use (C, F). 
Stati sti cal maps were thresholded at P < 0.05, with the colormap refl ecti ng the P-values, ranging 
from 0.05 (red) to 0.00 (yellow).
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Table 1. Demographic characteristics of the participants
Controls (n=80) Siblings (n=93) Patients (n=85)
Sex Male (%) 29 (36%) 49 (53%) 58 (68%)
Handedness 76.3 73.9 72.8
Age at scan (years) 30.8±10.8 29.4±8.8 28.3±7.0
Level of education 5.4±1.8 5.1±2.1 4.1±2.0
Age of onset (years) 22.8±6.4
Illness duration (years) - - 5.4±3.6
Antipsychoticsa - - 6692.71±6254.18
Cannabisb 7.8±21.9 19.3±37.2 44.0±47.0
Other drugsb 0.90±4.7 6.2±31.4 42.4±90.8
Alcoholc 5.0±7.0 9.8±17.3 5.0±9.1
PANSS
Positive symptoms 7.3±1.1 7.3±0.9 10.4±5.0
Negative symptoms 8.2±1.0 8.4±2.0 12.0±5.9
Disorganization 10.2±1.2 10.3±0.7 12.5±4.1
Excitement 8.3±1.1 8.6±1.4 9.7±2.7
Emotional Distress 9.2±2.1 9.9±2.6 13.2±5.2
Means ± SDs are reported
Abbreviations: PANSS, Positive and Negative Syndrome Scale
aLifetime exposure in haloperidol equivalents
bMean number of times; life time
cWeekly consumptions of the last 12 months
Table 2. Group differences in FA: results from TBSS
Brain Area Siblings vs. 
Patients
Controls vs. 
Patients
A B C
Genu of corpus callosum 826 841 928 800
Body of corpus callosum 1983 2421 2581 2380
Splenium of corpus callosum 92 346 412 165
Forceps major 94 276 326 122
Forceps minor 1068 1038 1149 984
Fornix (column and body of fornix) 0 0 0 0
Anterior limb of internal capsule, right 0 49 398 0
Anterior limb of internal capsule, left 0 213 48 0
Posterior limb of internal capsule, right 0 0 22 0
Posterior limb of internal capsule, left 0 1 0 0
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Table 2. Group differences in FA: results from TBSS (continued)
Brain Area Siblings vs. 
Patients
Controls vs. 
Patients
A B C
Retrolenticular part of internal capsule, right 0 4 2 0
Retrolenticular part of internal capsule, left 0 0 1 1
Anterior corona radiata, right 0 1037 1049 750
Anterior corona radiata, left 654 1157 1233 1120
Superior corona radiata, right 395 241 394 175
Superior corona radiata, left 221 468 470 382
Posterior corona radiata, right 339 373 406 0
Posterior corona radiata, left 13 442 443 416
Posterior thalamic radiation (incl. optic radiation), right 253 244 255 0
Posterior thalamic radiation (incl. optic radiation), left 0 313 352 260
Sagittal stratum (incl. inf. longitudinal fasc. and inferior 
fronto-occ. fasc), right
149 3 8 0
Sagittal stratum (incl. inf. longitudinal fasc. and inferior 
fronto-occ. fasc), left
0 5 46 35
External capsule, right 0 255 394 0
External capsule, left 0 371 425 400
Cingulum (cingulate gyrus), right 0 57 140 127
Cingulum (cingulate gyrus), left 23 0 0 0
Cingulum (hippocampus), right 0 0 0 0
Cingulum (hippocampus), left 0 0 0 0
Fornix, stria terminalis, right 0 19 27 0
Fornix, stria terminalis, left 0 4 18 16
Superior longitudinal fasciculus, right 0 0 269 0
Superior longitudinal fasciculus, left 0 184 198 173
Superior fronto-occipital fasciculus, right 103 65 69 0
Superior fronto-occipital fasciculus, left 0 64 62 0
Uncinate fasciculus, right 0 50 57 0
Uncinate fasciculus, left 0 53 58 56
Tapetum, right 0 35 35 0
Tapetum, left 0 5 5 5
The number of voxels with a significant higher FA (p <0.05) in the controls vs. the patients and 
the siblings vs. the patients. There were no regions with a significant higher FA in the siblings 
compared to the controls. Results were controlled (A) for age, sex, handedness, highest level of 
education, (B) age, sex, handedness, highest level of education and cannabis use, (C) age, sex, 
handedness, highest level of education, cannabis and other drug use.
Chapter 2
42
The patients showed a significantly lower FA compared to the control group in the fol-
lowing regions with > 250 voxels and thresholded at P<0.05: corpus callosum (genu, 
body, splenium), forceps major and minor, external capsule bilaterally, corona radiata 
(anterior, posterior) bilaterally, left superior corona radiata and posterior thalamic 
radiation bilaterally. At a more conservative threshold (P<0.01), the corpus callosum 
(genu, body), left external capsule en anterior corona radiata bilaterally remained 
significant (Fig. 2).
The mean FA values in the brain areas mentioned above showed a gradual decline 
from the controls to the siblings to patients (see Fig.1, results from multilevel ran-
dom regression procedures in Stata). Although mean FA values in the siblings were 
generally lower than FA values in the controls, these differences were neither large 
nor conclusive statistically.
Compared to the siblings, the patients showed a significantly lower FA in the following 
regions with > 250 voxels and thresholded at P<0.05: corpus callosum (genu, body), 
forceps minor, left anterior corona radiata, right superior and posterior corona radiata 
and the right posterior thalamic radiation. Only a few regions remained significant 
using a more conservative threshold, ie P<0.01: the right body of the corpus callosum 
and the right superior corona radiata (Fig. 2). All these regions overlapped with those 
standing out in the comparison between patients and healthy controls.
There were no regions with a higher mean FA in the patients compared to controls or 
with a higher mean FA in the siblings compared to the controls.
Additional covariates: cannabis and other drug use
The results described above were controlled for age, sex, handedness, and highest 
level of education. The analyses were repeated using the additional covariates of 
cannabis and other drug use. When only cannabis use was added as an additional 
covariate, the number of significant brain regions showing FA difference between the 
patients and the controls, as well the number of voxels per region was comparable to 
the analysis without cannabis use as a covariate. The right superior longitudinal fas-
ciculus became apparent as an additional area with a significant higher FA in controls 
than in the patients (see Table 2).
When both cannabis and other drugs were added as covariates, the number of white 
matter areas with significant FA differences between the patients and the controls 
slightly decreased, particularly on the right side of the brain. Effect sizes of the genu 
and body of the corpus callosum held, whereas the effect size of the splenium was 
decreased (Table 2). Overall, the effect of drug use on white matter tissue appeared 
to be minor in this sample.
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AP medication
When cumulative AP exposure was added in TBSS as an additional covariate, the num-
ber of significant voxels decreased markedly, but significantly lower FA in the patients 
compared to the controls remained present in the body of the corpus callosum and 
the right posterior corona radiata (> 250 voxels). The patient-sibling comparison did 
not show significant regional differences.
Cumulative AP exposure was also entered as an independent (dummy) variable (low 
exposure: n=22, medium exposure: n=22 and high exposure: n=21) to examine the 
effect on FA within the patients. No significant differences in mean FA values were 
found when high or medium AP exposure levels were compared to low AP exposure 
levels.
In addition, analysis in Stata showed that there was no significant association between 
lifetime AP use and FA (B=1.4 × 10-7, P=0.68).
Sex differences
Stratified TBSS analyses were done separating the male (n=29 controls, 49 siblings, 58 
patients) and the female subjects (n=51 controls, 44 siblings, 27 patients). This led to 
50% reduction in sample size and to an absence of significant regional differences in 
mean FA in the patient-control, patient- sibling and control-sibling comparisons.
Since the number of the participants varied considerably between the groups after 
separating them by sex (eg. far more male patients than controls, and vice versa 
for females), the analyses were repeated in equally sized groups, ie. three groups 
of 29 males and three groups of 27 females. The total number of significant voxels 
markedly decreased: 8% (=1291 voxels) left in the female patient-control comparison, 
and 28% (=1845 voxels) left in the male patient-sibling comparison. In females, the 
patient group showed significantly lower FA values compared to the controls, but not 
compared to the siblings, in the genu and body of the corpus callosum and the forceps 
minor (> 250 voxels). In males, the patient group showed significantly lower mean FA 
values compared to the siblings, but not compared to the controls, following a similar 
regional pattern as in the whole group analysis, with only the body of the corpus 
callosum exceeding 250 voxels. There were no significant mean FA differences in the 
sibling-control comparisons.
In addition, although there was a significant main effect of group in the model of 
FA (group, linear trend: B=-0.004, P=0.02; patients compared to controls: B=-0.007, 
P=0.02; siblings compared to controls: B=-0.002, P=0.45), the group × sex interaction 
was not significant (chi2: 1.04, P=0.60), suggesting that the effect of group is not 
conditional on sex.
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Exclusion of individuals with a history of affective disorder
Repeating the original analyses excluding siblings (8 males and 10 females) and con-
trols (1 male and 11 females) with a history of affective disorder resulted in an overall 
increase (+15%) of significant voxels in the patient-control comparison, and an overall 
decrease (-76 %) of significant voxels in the patient-sibling comparison. The regional 
pattern of patient-related decreased FA was not changed, except for the absence of 
the left anterior, superior and posterior corona radiata in the patient-sibling compa-
rison. No significant differences in mean FA values were found between the controls 
and the siblings.
Discussion
In this whole-brain DTI study, patients with a psychotic disorder, non-psychotic si-
blings and healthy controls were examined in order to identify microstructural white 
matter alterations that may be associated with the familial risk for schizophrenia. The 
results showed a gradual decline of mean FA from the controls to the siblings to the 
patients. Mean FA values were significantly lower in the patients compared to the 
controls in several major white matter tracts, while differences between the siblings 
and the controls did not reach statistical significance. Thus, microstructural white 
matter alterations may reflect brain pathology associated with the illness, illness 
related environmental factors, or its treatment, rather than genetic risk.
Findings in the patients
The results support the hypothesis that the patients with psychotic disorder com-
pared to the healthy controls have reduced connectivity in several brain regions, 
while no regions with increased FA were identified. This is in line with the majority 
of the previous evidence suggesting widespread FA decreases in schizophrenia 10, 13, 
28. A significantly lower mean FA in the patients in certain brain fasciculi and tracts 
may indicate dysfunctional axonal connectivity, which has been related to psychotic 
symptomatology. For example, smaller FA in the left superior longitudinal fasciculus 
has been associated with positive symptoms 45, in particular hallucinations 46 and 
smaller FA in posterior callosal fibers has been associated with negative symptoms 46.
In the present study, the most prominent FA decreases were found in the corpus 
callosum, in particular the anterior part (genu) of the corpus callosum. The corpus 
callosum and its postulated role in the dysconnectivity hypothesis in schizophre-
nia are highlighted in several studies, but there is no consensus about which part 
of the corpus callosum is most affected; the anterior part 47 or the more posterior 
interhemispheric connections 48. The results from the present study showed that 
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the anterior-middle part was most affected, but also suggest that the entire corpus 
callosum may in fact be involved. These FA decreases in the corpus callosum provide 
additional evidence for aberrant cerebral interhemispheric activity in callosal fibers, 
further strengthening the theory that dysconnection in white matter connectional 
architecture in this part of the brain plays an important role in the core pathology 
of schizophrenia 49, 50. Indeed, aberrant connectivity in the corpus callosum has been 
associated with social cognition and interhemispheric information transfer deficits 51, 
52, as well as positive and negative symptoms 14, 53.
Findings in the siblings
Only a few studies with relatively small samples sizes, have examined FA in first-degree 
relatives of patients with psychotic disorder. Clark et al. (2011) found decreased FA 
in both patients and non-psychotic first-degree relatives in the left and right inferior 
longitudinal fasciculus, the left inferior fronto-occipital fasciculus and the temporal 
component of the superior longitudinal fasciculus, using a ROI approach 23. The ef-
fect sizes for the relatives were intermediate to those for the patients and controls. 
Other studies have reported significant white matter abnormalities in first-degree 
relatives compared to controls in the prefrontal cortex and hippocampus 24, medial 
frontal regions 22, the anterior limb of the internal capsule 26 and the corpus callosum 
25. One recent family study, comprising larger samples than hitherto, reported absence 
of FA alterations in most white matter tracts in siblings as compared to patients with 
schizophrenia and controls, except for an increased FA in the right arcuate fasciculus 21.
Although in the present study, the mean FA in the significant areas between the 
controls and the patients reflected a dose response effect of familial risk in that the 
values were highest in controls and lowest in the patients, with intermediate values 
for the siblings, there were no significant differences between the sibling and the 
control group. In addition, there were significant changes in the patient versus sibling 
comparison, suggesting that the siblings are more similar to the controls than the 
patients. In other words, the present study does not provide strong evidence for a 
microstructural white matter intermediate phenotype, but rather suggests that the 
microstructural white matter alterations are contingent on the expression of psycho-
tic illness. As cross-sectional studies do not allow conclusions on direction of effect, 
fiber dysconnectivity could in fact arise from the disease process or disease-related 
differential exposure to environmental risk factors or medication use.
Antipsychotic medication
Qualitative reviews have suggested that AP use may affect brain structure 54, 55. A 
recent, fairly large longitudinal study found that white matter volume loss was as-
sociated with more extensive use of antipsychotics even after adjustment for illness 
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duration, illness severity, and substance abuse 56. However, cross-sectional DTI studies 
with patients who were either medication-naïve or briefly medicated did not find 
evidence for a significant association between FA and antipsychotic exposure 57, 58. 
In the present study, extensive TBSS and Stata analyses both supported absence of 
significant effects of cumulative AP exposure on FA, except for one specific analysis in 
TBSS, in which AP exposure was added as a covariate and, consequently, the number 
of significant voxels between the patients and the controls markedly decreased (by 
79%). This, however, likely is an effect of the randomize procedure in FSL, where all 
controls and siblings receive a zero value for AP exposure leading to skewed distri-
butions in the equation and distortion of the results (i.e. controlling for AP is like 
controlling for patient-status itself). Moreover, despite the voxel reduction in this 
analysis, significantly lower FA in the patients compared to the controls remained 
present in the body of the corpus callosum and the right posterior corona radiate (> 
250 voxels), showing the robustness of FA differences in these areas. Lastly, altered FA 
values have been detected in AP-naïve patients 59-61, suggesting that AP exposure may 
at best contribute to, but not fully explain, the white matter alterations.
Environmental factors
Specific (epi)genetic or environmental effects and/or gene-environment interplay may 
have contributed to the emergence of structural dysconnectivity in patients. Evidence 
for gene effects has come from studies with healthy subjects and studies with patients 
showing associations between polymorphisms of myelin-associated genes, such as 
NRG1, ErbB4 and PIK4CA on the one hand, and white matter integrity in the anterior 
cingulum, the anterior limb of the internal capsule and frontotemporal fibers on the 
other 17, 62-65.
Certain environmental factors, such as childhood trauma 66 and urban upbringing 
67 have been associated with cerebral alterations in respectively traumatized and 
non-psychiatric populations. Although these environments are risk factors for schi-
zophrenia 68 they have never been examined in relation to cerebral white matter in 
this patient population. The influence of cannabis on white matter volume in schi-
zophrenia is weak 69, 70 but DTI studies have shown both FA increases and decreases 
in cannabis-using patients with schizophrenia compared to non-using patients 28, 
71. Previous analyses on the present study sample have demonstrated that familial 
predisposition for psychotic disorder is associated with greater cannabis-induced re-
duction in cortical thickness 72. The current DTI results suggest that there is no marked 
effect of cannabis on microstructural white matter, as the controlling TBSS analyses 
for cannabis use did not change the results. However, the number of white matter 
areas that were significantly different between the patients and the controls slightly 
decreased in the model that included other drug use as a covariate. This may indi-
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cate that non-cannabis drug use may have a subtle, though measurable, effect on 
microstructural white matter in patients with psychotic disorder. To date, there are no 
other DTI studies reporting on an association between FA and non-cannabis drug use 
in individuals with psychotic disorder. In healthy (non-psychotic) individuals, other 
drug use (cocaine, heroin) has been negatively associated with FA in several brain 
areas, including the corpus callosum 73-75. Thus, other drugs may affect the integrity of 
white matter brain tracts in individuals with psychotic disorder as well as in healthy 
(non-psychotic) individuals.
The possible influence of environmental risk factors on white matter tissue warrants 
further investigation.
Sex differences
Several studies have addressed sex differences in FA in healthy individuals. For the 
corpus callosum, both higher FA values in women compared to men 76, higher FA 
values in men compared to women 77, as well as no sex differences 78 have been repor-
ted. In patients with schizophrenia, the literature on sex differences in FA is limited, 
but suggests lower values in women compared to men in the genu 79 and the whole 
corpus callosum 80. In the present study, the absence of significant group differences 
in regional FA in males and females separately could be the result of lack of power 
and markedly unequal group sizes after stratification by sex. Indeed, when stratified 
analyses were done in equally sized groups, there were patient-control differences in 
females, but not in males, and sibling-patient differences in males, but not in females. 
Multilevel analyses in Stata, however, did not yield support for a group × sex interac-
tion. The contrasting results between TBSS and Stata analyses could be the result of 
methodological differences (voxelwise analyses of aligned FA data projected on the 
mean FA skeleton, versus multilevel regression analyses on the skeleton mean FA’s of 
38 regions).
In conclusion, the significant FA reductions in the patients may be more female than 
male driven, which needs replication in larger samples. The absence of reduced FA in 
the siblings compared to the controls, however, was consistent in all analyses, thus 
consistently providing evidence for the absence of an intermediated phenotype.
Methodological considerations
Since FA decreases in cortical and subcortical areas have been found in patients with 
major depression 81, a priori planned sensitivity analyses were done excluding all 
individuals with a history of affective disorder. Although the number of significant 
voxels varied, which may be due to a different sex distribution between the groups as 
the majority of the excluded participants were females, it did not alter the regional 
pattern of significant white matter tracts.
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Structural neuroimaging studies often differ in scanning acquisition and imaging 
processing. These differences could have contributed to discrepancies in outcome. 
The present study was the second family study using a 3T scanner. The signal-to-noise 
ratio using this field strength is better, as is the visibility of certain details compared 
to a 1.5T scanner. Also, the sequence alteration due to a scanner update could in 
theory have influenced our results. However, we repeated the TBSS analyses, with 
the number of scan directions as additional covariate. The number and pattern of 
significant findings was not affected (results available on request).
Other methodological differences are reflected in the type of analyses: hypothesis-ge-
nerating whole-brain voxel-wise analysis versus the hypothesis-testing ROI approach. 
It is known that due to image misregistration, smoothing and partial volume effects, 
whole brain voxel-wise analysis often yields different results compared to the region 
of interest (ROI) studies 82, 83.
In DTI studies, different atlases are used in establishing the exact regions of white 
matter alterations. These atlases differ considerably in the definitions of the bounda-
ries of particular white matter tracts and of the labeling of certain brain regions, in an 
attempt to account for overlap and crossing fibers. We used two versions of the white 
matter JHU atlas 42, 43 to include most major white matter tracts. The differences in 
atlases among the DTI studies hamper between-study comparisons.
Conclusion
This large cross-sectional DTI study examined white matter integrity in relation to 
different levels of familial risk for psychotic disorder. There was evidence for patient-
specific alterations in microstructural white matter, most profoundly present in the 
corpus callosum, with no evidence for an intermediate phenotype. The widespread 
disruptions in white matter in patients with schizophrenia may reflect disease-related 
dysconnectivity, or disease-related differential exposure to environmental risk factors 
contributing to the symptoms of schizophrenia.
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ABSTRACT
Background. Although widespread reduced white matter integrity is a consistent fin-
ding in cross-sectional DTI studies of schizophrenia, little is known about the course of 
these alterations. This study examined to what degree microstructural white matter 
alterations display differential trajectories over time as a function of level of psychosis 
liability.
Methods. Two DTI scans with a 3-year time interval were acquired from 159 partici-
pants (55 patients with a psychotic disorder, 55 non-psychotic siblings and 49 healthy 
controls) and processed with tract-based spatial statistics (TBSS). The mean FA change 
over time was calculated. Main effects of group, as well as group × region interactions 
in the model of FA change were examined with multilevel (mixed-effects) models.
Results. Siblings revealed a significant mean FA decrease over time compared to con-
trols (B=-0.004, p=0.04), resulting in a significant sibling-control difference at follow-
up (B=-0.007, p=0.03). Patients did not show a significant change over time, but their 
mean FA was lower than controls both at baseline and at follow-up. A significant 
group × region interaction (χ2: 105.4, p=0.01) revealed group differences in FA change 
in the right cingulum, left posterior thalamic radiation, right retrolenticular part of the 
internal capsule and the right posterior corona radiata.
Conclusion. Whole brain mean FA remained stable over a 3-year period in patients 
with psychotic disorder and declined over time in non-affected siblings, so that at 
follow-up both groups had lower FA with respect to controls. The results suggest that 
liability for psychosis may involve a process of white matter alterations.
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Introduction
The functional dysconnectivity hypothesis of schizophrenia suggests that symptoms 
originate as a result of miscommunication between different brain areas 1, 2, associ-
ated with microstructural white matter (WM) alterations. Diffusion tensor imaging 
(DTI) is used to identify potential WM microstructural correlates. Fractional aniso-
tropy (FA) combines information on myelination, fiber density and number of axons 
in one measure, whereas additional diffusion parameters (axial-, radial-, and mean 
diffusivity) may provide more specific information on white matter integrity 3. A large 
number of cross-sectional DTI studies of patients in early and later stages of schizo-
phrenia have shown decreased FA with respect to controls in several white matter 
tracts throughout the brain 4, 5. However, it is not clear when these WM alterations oc-
cur and how they develop over time 6. Both a neurodevelopmental model 7, 8, implying 
that white matter alterations are present before disease onset and a post-onset pro-
gression model, indicating that structural brain abnormalities progress over time after 
disease onset, have been proposed 9, 10. In support of the neurodevelopmental model, 
several cross-sectional DTI studies have revealed microstructural WM alterations in 
frontotemporal and –parietal connections in first-degree relatives without symptoms 
11, 12, in clinical high-risk populations before onset 13, 14, and in patients with early onset 
psychosis 15. Indeed, the lifetime trajectory of WM alterations in schizophrenia sug-
gests higher percentages of WM loss in the first years of the illness, implicating altered 
neurodevelopment 6, 16. The literature on longitudinal WM changes, however, is too 
limited to draw firm conclusions on neurodevelopmental or progressive changes, as 
well as the role of medication 16. A study by Carletti and colleagues (2012) showed a 
significant progressive reduction in FA in the left frontal white matter in individuals at 
‘Ultra-High Risk’ (UHR) who developed psychosis compared to UHR subjects who did 
not make a ‘transition’ 17. Reis Marques and colleagues (2014) found an increase in 
FA in first episode patients (both responders and non-responders to AP medication) 
over a 12-week period 18, and Garver and colleagues (2008) reported reduced mean 
diffusivity after 28 days of treatment in drug-responding patients with schizophrenia, 
which was not found in non-responders 19. A fourth study compared WM FA changes 
between individuals during a more chronic course of schizophrenia (n=49) and he-
althy controls (n=16), reporting a stronger FA decline over 4 years in frontal, temporal, 
and parietal WM in the controls. A subgroup of patients with poor outcome could 
be differentiated from a group with good outcome by regional progression of WM 
alterations in an adjacent precentral/postcentral area 20.
Not only DTI, but also longitudinal volumetric studies are scarce. Decreases over time 
have been described in recent onset and first-episode patients in frontal lobe white 
matter volume 21 and temporal lobe WM volume, respectively 22. However, in patients 
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aged up to 51 years, van Haren and colleagues (2008) described an abnormal curved 
trajectory of volume change, with normalization of age-related volume change later 
in life 23.
In our recent cross-sectional diffusion analyses of patients with a psychotic disorder, 
siblings and controls (n=258), patient-specific microstructural WM alterations were 
found in the corpus callosum and other WM tracts 24. This sample was re-scanned 
approximately 3 years later to examine whether the evolution of FA over time varies 
as a function of familial risk for psychotic disorder.
Methods
Participants
Participants were recruited in the context of a multicentre longitudinal study (Genetic 
Risk and Outcome of Psychosis, G.R.O.U.P.) in the Netherlands 25. The MRI add-on 
study was conducted in Maastricht, the Netherlands (see Domen and colleagues 24 
or the Supplemental Method section for full information on in- and exclusion criteria 
of the participants and diagnostic assessments). For the baseline MRI study, 300 
participants were included of which 258 provided a valid DTI scan: 85 patients with a 
psychotic disorder, 93 siblings without a psychotic disorder, and 80 healthy controls. 
At follow-up, approximately three years later (mean: 3.3 year), a second DTI scan was 
acquired from 180 participants (loss to follow-up of 40%). The final sample comprised 
159 participants (55 patients with a psychotic disorder, 55 siblings without a psychotic 
disorder, and 49 healthy controls), for which a pair of DTI scans was available for 
longitudinal analysis (Table 1).
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Table 1. Demographic Characteristics of the Participants (n=159)
Controls (n=49) Siblings (n=55) Patients (n=55)
Time point 0 1 0 1 0 1
Scan interval (days) 1222±198 1177±101 1196±121
Age at scan (years) 31.0±11.0 34.4±10.9 30.9±8.5 34.1±8.5 28.7±6.3 32.0±6.2
Sex Male (%) 19 (39%) 29 (53%) 40 (73%)
Handedness 83.2 78.0 72.2
Level of education 5.4±2.0 5.4±2.1 4.5±1.9
Age of onset (years) - - 21.8±6.3
Illness duration (years) - - 5.7±3.5 10.3±4.0
AP medication - - 6693±
6254a
5335±
5715b
Diagnosis
Schizophrenia - - 33
Schizoaffective disorder - - 16
Psychotic disorder NOS - - 6
Major depressive 
disorderc
11 15 -
Substance use
Cannabis 4.8±32.0d 7.1±49.1d 36.5±105.2d
Other drugs 0.0 0.0 15.2±57.0d
Alcohol 6.3±10.8e 6.0±5.4e 4.9±7.6e
PANSS scores
Positive symptoms 7.3±1.2 7.4±0.8 7.4±0.9 7.4±0.7 9.6±3.7 11.6±5.7
Negative symptoms 8.2±1.2 8.0±0.2 8.2±1.3 8.0±0.3 11.4±5.2 11.1±4.2
Disorganization 10.3±1.5 10.1±0.3 10.3±0.6 10.1±0.4 11.7±2.6 11.8 ±2.5
Excitement 8.4±1.3 8.3±0.5 8.5±1.2 8.3±0.6 9.4±1.9 9.7±2.5
Emotional Distress 9.3±2.1 9.4±1.7 9.7±2.2 9.7± 2.2 12.9±5.2 14.1±5.0
Remission (percentage) - - - - 61% 62%
Means ± SDs are reported. AP, Antipsychotics; NOS, not otherwise specified; PANSS, Positive and 
Negative Syndrome Scale.
a Cumulative exposure (in haloperidol equivalents), lifetime until baseline assessment
b Exposure (in haloperidol equivalents) over last 3 years
c History of major depressive disorder, no current episodes at baseline or in last three years
d Mean number of times; last 12 months
e Weekly consumptions last 12 months
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The sample included 129 families of which 16 families contributed one patient and 
one healthy sibling and 1 family contributed one patient and two healthy siblings. 
Six families contributed two healthy siblings, one family contributed three healthy 
siblings and four families contributed two healthy controls. In addition, 38 families 
contributed a single patient, 22 families contributed a single sibling, and 41 families 
contributed a single control.
The standing ethics committee approved the study protocol, and all participants gave 
written informed consent in accordance with the committee’s guidelines.
Measures
Symptoms
At both time points, symptoms were assessed with the Positive and Negative Syndro-
me Scale (PANSS) 26. The five factor model by van der Gaag and colleagues (2006) was 
used, dividing the PANSS in positive symptoms, negative symptoms, disorganization 
symptoms, excitement, and emotional distress 27. The scores of the individual items of 
the 5 symptom dimensions were summed. To assess clinical remission, the operatio-
nalized criteria described by Andreasen and colleagues (2005) 28 were applied.
Educational level (at baseline) was defined as the highest accomplished level of edu-
cation. Handedness was assessed using the Annett Handedness Scale 29.
Medication
In the patient group, antipsychotic (AP) medication use was determined by patient 
report and verified with the treating consultant psychiatrist. Best estimate lifetime 
(cumulative) AP use at baseline was determined by multiplying the number of days of 
AP use with the corresponding haloperidol equivalents and summing these scores for 
all periods of AP use (including the exposure period between baseline assessment for 
the G.R.O.U.P. study and the moment of baseline MRI scanning), using the published 
converting formulas for AP dose equivalents described by Andreasen and colleagues 
30. The same procedure was used for calculating cumulative AP exposure during the 
3-year follow-up period.
Substance use
Substance use was measured at both time points with the Composite International 
Diagnostic Interview (CIDI) sections B-J-L 31. Alcohol use was defined as the reported 
number of weekly consumptions during the last 12 months. As data on drug use of 
the last 3 years was not available, cannabis and other drugs was assessed as reported 
frequency of use during the last 12 months, as well as lifetime use. CIDI frequency 
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data on alcohol, lifetime cannabis and other drug use was available at baseline for 
respectively 158 participants (1% missing data), 155 participants (3% missing data), 
and 157 participants (1% missing data).
Image acquisition
Magnetic resonance imaging scans were obtained at Maastricht University, the Net-
herlands, using an Allegra Magnetom MR (Siemens, Erlangen, Germany) operating at 
3.0 Tesla. At both measurement points, microstructural anatomy was examined using 
diffusion tensor imaging with an echo-planar-imaging sequence (field of view 230 
× 230 mm2, TR 10800 ms, TE 84 ms, voxel size 1.8 × 1.8 × 1.8 mm³, b-value 1000 s/
mm², 85 slices, no overlap). As a result of a scanner update at the baseline measure-
ment, two DTI sequences were used: one with 76 directions (of which four diffusion-
unweighted (B0) and 72 diffusion-weighted (B1000)) and one with 81 directions 
(8×B0 and 73×B1000). A potential association between the proportion of baseline 
scans and group was investigated using a Pearson chi-square test. At follow-up, the 
DTI sequence comprised 81 directions (8×B0 and 73×B1000). Total acquisition time of 
the DTI sequence was 15 minutes.
Diffusion tensor imaging analysis
DTI data were processed using tract-based spatial statistics (TBSS) v1.2 in FSL 4.1.6 
(FMRIB Analysis Group, Oxford, UK, http://www.fmrib.ox.ac.uk/analysis/research/
tbss). First, standard Siemens DICOM files were transformed into compressed NIFTI 
format using a custom built in-house software named GIANT (General Image ANalysis 
Tools developed by EG). Raw data were corrected for head movement and eddy cur-
rents invoked during scanning. The B0 volume was skull-stripped using FSL’s Brain 
Extraction Tool 32 and this served as a brain mask for all B volumes.
The next step was fitting a diffusion tensor model at each voxel using data output 
from the brain extraction, diffusion weighted data and gradient directions following 
a general linear model (FreeSurfer v4.5.0, http://www.freesurfer.net). After tensor 
fitting (using the DT-Recon script) the process continued working on FA volumes, 
eroding them slightly. Nonlinear registration aligned each FA volume to 1 x 1 x 1 mm 
standard FMRIB58_FA space. The standard FMRIB58_FA contains a template derived 
from high-resolution images of 58 participants in a well-aligned population (both 
males and females ranging between 20 and 50 years of age) 33.
After nonlinear transformation of the FA volumes into standard space, two mean 
FA skeletons were created; i) one based on three groups (n=159: controls, siblings, 
patients) for the cross-sectional analysis at follow-up and ii) one based on six groups 
(3 groups × 2 time-points) for the longitudinal analysis. The mean FA skeleton follows 
the major WM tracts in each individual participant (normalized in MNI152 space) and 
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provides a way to compare between (groups of) participants. The FA threshold was 
set, using visual inspection of the FA skeleton, at a level of 0.25, to include major 
WM tracts whilst removing small peripheral tracts that would cause excess inter-
participant variability. In addition, this threshold setting avoided inclusion of regions 
that are likely to be composed of multiple tissue types or fiber orientations. In the 
final step, a binary skeleton mask was created and used to extract FA values of the 
individual participants. The Johns Hopkins University International Consortium for 
Brain Mapping (JHU ICBM)-DTI-81 white-matter atlas labels 34 were used to label all 
voxels and assign a specific tract name. If the voxels did not match with the JHU ICBM 
labels, they were identified using the JHU white-matter tractography atlas 35.
Statistical analyses
From the 38 JHU labelled white matter tracts, skeleton mean FA values per participant 
per time point were extracted and exported to R (version 3.2.0), a free software envi-
ronment for statistical computing and graphics 36.
Longitudinal analyses
Within-group paired t-tests were done to examine the difference in regional mean FA 
between baseline and follow-up. Subsequently, a mean FA “change” (delta, Δ per par-
ticipant per region) was calculated by subtracting mean FA (baseline) from mean FA 
(follow-up). The data set was transformed from a wide to a hierarchically structured 
data set, with 38 regional ΔFA measures (Level 1) nested in subjects (Level 2) who were 
part of the same families (Level 3). A mixed- effects model was used to examine the 
model with ΔFA measures as the dependent variable and scan-interval as additional 
covariate. In addition, since the outcome represents means based on varying number 
of voxels (depending on the region), we used a model in which the error variance for 
a particular observation was inversely weighted by the number of voxels within the 
corresponding region (i.e., since the variance of a mean is equal to the variance of 
a single observation – in this case voxel – divided by the number of values used for 
the averaging). Main effects of group, corrected for age, sex, handedness, level of 
education and scan-interval, as well as group × sex and group × region interactions 
in the model of ΔFA were examined. In each of the 38 regions, between-group factor 
significance was tested. Regions with a significant group effect were examined with 
pairwise comparisons (i.e., it was tested whether ΔFA differed between patients and 
controls, between siblings and controls, and between patients and siblings).
Due to the large number of regions (and hence tests), Simes’ procedure 37, 38 was used 
to control the false discovery rate when testing the regional within-group mean FA 
differences between baseline and follow-up, the between-group effects within the 38 
regions and the pairwise comparisons.
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Sensiti vity analyses were performed with last year cannabis use, lifeti me cannabis use 
and scan type (76 or 81 directi ons) as additi onal covariates in three separate models. 
Since a subgroup of parti cipants in the control (n=11) and sibling group (n=15) had 
a history of a depressive disorder (and a number of DTI studies with pati ents with a 
major depressive disorder have shown decreased FA in several corti cal and subcorti cal 
WM tracts 39), additi onal sensiti vity analyses were conducted controlling for history 
of depression.
AP medicati on
In pati ents only, the associati on between ΔFA and respecti vely last 3-year and lifeti me 
AP use was examined. These variables were entered both as linear and as factored 
variables (ie, representi ng the distributi on of scores divided by its terti les: low, 
moderate or high AP exposure), allowing visualizati on of dose–response. Sensiti vity 
analyses were done using pati ent subgroups (with low, moderate, high AP exposure), 
ie, the associati on between group and ΔFA was examined per AP subgroup to examine 
whether pati ents with diff erenti al AP exposure would have diff erenti al FA change over 
ti me in comparison to controls and siblings.
Cross-secti onal analyses at follow-up
To examine group diff erences at follow-up (n=159), a whole-brain mean FA was com-
puted with the 38 WM regions conform the above-described procedure. Whole-brain 
FA was the dependent variable and random eff ects (intercepts) were added for each 
subject and family, including a priori hypothesized confounding variables age, sex, 
handedness, and level of educati on as fi xed eff ects.
Results
Parti cipant characteristi cs
The characteristi cs of the 159 individuals with a baseline and follow-up scan are 
displayed in Table 1. The majority of the pati ents were not in need of inpati ent care 
or intensive treatment, as refl ected by the low PANSS scores at both ti me points and 
the proporti on of pati ents in remission. At baseline, 54 pati ents were receiving AP 
medicati on with a mean dosage in terms of standard haloperidol equivalents of 5.4 
milligrams (mg) (SD = 3.4). At follow-up, 45 pati ents used AP medicati on (second 
generati on: n=42; fi rst generati on: n=3), with a mean dosage of 4.7 milligrams (mg) 
(SD = 5.1). The lifeti me cumulati ve AP exposure was 13079.7 mg (SD = 10977.2).
The proporti on of baseline scans with 76 directi ons did not diff er between the groups 
(84% in controls, 82% in siblings, and 71% in pati ents: χ2 =3.02, df=2, P= 0.22).
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Whole-brain group diff erences in FA change over ti me (ΔFA)
The mean ΔFA revealed a slight increase over ti me in the controls (0.001) and a decre-
ase over ti me in the siblings (-0.003) and pati ents (-0.0002), with the mean FA (0.504) 
of the siblings at follow-up in between that of the controls (0.509) and the pati ents 
(0.502) (Fig. 1). At follow-up, there were more white matt er tracts showing a decrease 
than an increase in pati ents and siblings (27 and 23 of the 38 tracts respecti vely), 
whereas in controls the proporti on of decreases and increases was balanced (Table 2).
 
 
 
Fig. 1. Group differences in whole brain FA at follow-up. Error bars represent the SE 
of the mean ΔFA at baseline and at follow-up. FA, fractional anisotropy 
  
Fig. 1. Group diff erences in whole brain FA at follow-up. Error bars represent the SE of the mean 
ΔFA at baseline and at follow-up. FA, fracti onal anisotropy
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Table 2. Mean FA per Group at Baseline and at Follow-up
Brain region Mean FA
Controls Siblings Patients
T0 T1 Δ T0 T1 Δ T0 T1 Δ
Genu of corpus callosum .7570 .7557 -.0012 .7551 .7515 -.0036 .7466 .7446 -.0020
Body of corpus callosum .7214 .7216 .0003 .7175 .7155 -.0020 .7035 .7007 -.0028
Splenium of corpus callosum .7877 .7915 .0037 .7891 .7873 -.0018 .7880 .7897 .0017
Forceps major .7004 .7042 .0038* .6974 .6956 -.0018 .6904 .6896 -.0009
Forceps minor .5850 .5848 -.0002 .5827 .5800 -.0026 .5785 .5779 -.0006
Fornix (column & body) .5278 .5199 -.0078 .5305 .5208 -.0097 .4812 .4855 .0043
Ant. limb of int. capsule, right .6311 .6213 -.0098* .6242 .6154 -.0088* .6215 .6129 -.0086*
Ant. limb of int. capsule, left .6083 .6194 .0111* .6024 .6102 .0079* .6003 .6116 .0113*
Post. limb of int. capsule, right .6949 .6903 -.0046 .6924 .6859 -.0065* .6954 .6906 -.0048
Post. limb of int. capsule, left .6934 .6942 .0008 .6917 .6903 -.0014 .6977 .6953 -.0024
Retro. part of int. capsule, right .5807 .5993 .0186* .5819 .5901 .0082 .5834 .5901 .0066
Retro. part of int. capsule, left .5985 .5883 -.0102* .5951 .5859 -.0092* .5935 .5902 -.0033
Anterior corona radiata, right .5192 .5119 -.0073 .5150 .5043 -.0108* .5056 .4947 -.0110*
Anterior corona radiata, left .5037 .5084 .0047 .4979 .4980 .0002 .4885 .4942 .0057
Superior corona radiata, right .5267 .5297 .0030 .5239 .5240 .0001 .5186 .5191 .0006
Superior corona radiata, left .5319 .5207 -.0111* .5261 .5169 -.0091* .5235 .5121 -.0114*
Posterior corona radiata, right .5172 .5115 -.0057 .5094 .4945 -.0150* .5062 .4873 -.0189*
Posterior corona radiata, left .5010 .5134 .0125* .4892 .5018 .0125* .4835 .4999 .0163*
Post. thalamic radiation, right .6269 .6260 -.0009 .6207 .6162 -.0045 .6180 .6081 -.0099
Post. thalamic radiation, left .6179 .6255 .0076 .6105 .6094 -.0011 .6011 .6123 .0111
Sagittal stratumn, right .5732 .5744 .0012 .5687 .5637 -.0050 .5656 .5635 -.0020
Sagittal stratumn, left .5706 .5746 .0040 .5609 .5625 .0016 .5617 .5641 .0024
External capsule, right .4769 .4770 .0001 .4741 .4690 -.0050 .4711 .4679 -.0032
External capsule, left .4731 .4755 .0024 .4679 .4698 .0020 .4652 .4715 .0063
Cingulum (cing. gyrus), right .6104 .6403 .0299* .6099 .6333 .0233* .6072 .6378 .0305*
Cingulum (cing. gyrus), left .6391 .6048 -.0343* .6344 .6016 -.0328* .6344 .6023 -.0320*
Cingulum (hippoc), right .5556 .5585 .0029 .5602 .5393 -.0210* .5535 .5445 -.0090
Cingulum (hippoc), left .5486 .5702 .0216* .5421 .5552 .0131 .5417 .5599 .0182*
Fornix, stria terminalis, right .5581 .5806 .0225* .5547 .5701 .0153* .5454 .5671 .0217*
Fornix, stria terminalis, left .5625 .5562 -.0063 .5590 .5433 -.0156* .5509 .5426 -.0084
Sup. longitudinal fasc., right .5298 .5313 .0015 .5325 .5297 -.0028 .5320 .5241 -.0079
Sup. longitudinal fasc., left .5303 .5243 -.0060 .5305 .5258 -.0047 .5271 .5233 -.0038
Sup. fronto-occipital fasc.,right .5380 .5308 -.0072 .5329 .5281 -.0048 .5214 .5155 -.0060
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Table 2. Mean FA per Group at Baseline and at Follow-up (continued)
Brain region Mean FA
Controls Siblings Patients
T0 T1 Δ T0 T1 Δ T0 T1 Δ
Sup. fronto-occipital fasc., left .5276 .5252 -.0023 .5189 .5188 -.0001 .5097 .5123 .0026
Uncinate fasciculus, right .5523 .5516 -.0006 .5393 .5413 .0019 .5395 .5387 -.0008
Uncinate fasciculus, left .5263 .5179 -.0084 .5109 .5074 -.0035 .5071 .5108 .0037
Tapetum, right .6164 .6121 -.0042 .5907 .5824 -.0083 .5910 .5714 -.0196*
Tapetum, left .6345 .6343 -.0002 .6106 .5983 -.0124 .5942 .5812 -.0130
Note: Δ = mean FA difference (mean FA follow-up – mean FA baseline), with values in italics 
representing FA decreases and bold representing FA increases. FA, fractional anisotropy
n incl. inferior longitudinal fasciculus and inferior fronto-occipital fasciculus
* Results of a within-group paired t-test examining significant within group ΔFA differences per 
brain region (P<0.05), accounting for a false discovery rate with the Simes’ procedure (38 regions 
× 3 groups) (*PSimes< .003).
There was no significant association between group and ΔFA (χ2: 4.9, df=2, p=0.09). 
Although the direction of effect for patients compared to controls indicated a decre-
ase in FA over time, the difference was not significant (B=-0.002, p=0.19); additional 
correction for last year cannabis use, lifetime cannabis use and scan type did not 
change the results of the patient-control comparisons (B=-0.002, p=0.22; B=-0.002, 
p=0.30 and B=-0.002, p=0.17 respectively). In siblings compared to controls, there 
was a significant decrease in FA (B=-0.004, p=0.04). This effect remained significant 
when controlled for scan type (B=-0.004, p=0.04) and last year cannabis use (B=-
0.004, p=0.04), and close to significant when controlled for lifetime cannabis use 
(B=-0.003, p=0.07) and history of depression (B=-0.003, p=0.06). No significant group 
× sex interaction in the model of ΔFA (χ2=0.9, df=2, p=0.62) was found.
Regional group differences in ΔFA
There was a significant group × region interaction in the model of ΔFA (χ2: 105.4, 
df=74, p=0.01), indicating that group differences varied as a function of region. The 
group factor was significant in 6 of the 38 regions, of which four regions survived after 
Simes’ correction. Patients had a significant smaller FA increase in the right retrolenti-
cular part of the internal capsule (RPIC), and a decrease in the right cingulum and the 
right posterior corona radiate (PCR) compared to controls. Siblings had a significant 
smaller FA increase in the right RPIC and a decrease in the right cingulum compared 
to controls. In comparison to patients and controls, siblings had a decrease in the left 
posterior thalamic radiation (PTR) (Table 3, Fig. 2).
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Fig. 2. Group × region interactions in the model of ΔFA. Group differences in mean 
ΔFA in four WM tracts are displayed (PSimes < .02), corresponding with table 3. Error 
bars represent the SE of the mean ΔFA at baseline and at follow-up. FA, fractional 
anisotropy 
  
Fig. 2. Group × region interacti ons in the model of ΔFA. Group diff erences in mean ΔFA in four 
WM tracts are displayed (PSimes < .02), corresponding with table 3. Error bars represent the SE of 
the mean ΔFA at baseline and at follow-up. FA, fracti onal anisotropy
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Table 3. Group Comparisons in Regions with a Signifi cant Group Eff ect
Brain Region Between-
group eff ect
Pati ent-
Control
Sibling-
Control
Pati ent-
Sibling
(χ2, df=2, P) (B, P) (B, P) (B, P)
RPIC, right 11.8, 0.003a -0.01, 0.001* -0.01, 0.008* -0.003, 0.49
Posterior corona radiata, right 10.5, 0.005a -0.01, 0.001* -0.009, 0.03 -0.004, 0.29
Posterior thalamic radiati on, right 9.0, 0.01 -0.01, 0.003 -0.004, 0.27 -0.007, 0.05
Posterior thalamic radiati on, left 14.2, 0.0008a 0.004, 0.31 -0.009, 0.01* 0.01, 0.0003*
Cingulum, right 19.6, 0.0001a -0.01, 0.01* -0.02, 9.7 × 10-6* 0.01, 0.05
Superior longitudinal fasciculus, right 9.4, 0.009 -0.01, 0.002 -0.004, 0.15 -0.005, 0.08
Note: The χ2 and the P-values represent the signifi cant results of the between-group factor 
analyses per region in multi level modelling (aPSimes < .005). B and P-values of the individual group 
comparisons are shown (*PSimes < .02). Analyses are controlled for age, sex, handedness, level of 
educati on, and scan interval. RPIC, Retrolenti cular part of internal capsule
Anti psychoti c (AP) medicati on
Within-pati ents analyses showed that there was a close to signifi cant associati on 
between lifeti me AP use (linear) and whole-brain mean ΔFA (B=-2.5 × 10-7, p=0.08). 
Compared to low lifeti me AP exposure, pati ents with high AP exposure showed sig-
nifi cantly more FA decrease over ti me (B=-0.008, p=0.04), which was not the case for 
pati ents with moderate exposure (B=-0.005, p=0.15). With regard to AP exposure over 
the last three years, a signifi cant negati ve associati on was found between cumulati ve 
AP exposure (linear) and whole brain mean ΔFA over the last three years (B=-5.6 × 
10-7, p=0.01). Higher levels of AP medicati on over the last three years predicted a 
stronger decrease in FA: moderate vs. low exposure: B=-0.006, p=0.04; high vs. low 
exposure (B=-0.009, p=0.004).
The group analyses based on AP medicati on subgroups (low, moderate, high cumula-
ti ve AP medicati on exposure) showed that there was a signifi cant decrease in FA over 
ti me in pati ents with the highest level of AP exposure (lifeti me and over the last three 
years) compared to controls, but not in pati ents with moderate or low AP exposure. 
Siblings showed a signifi cant stronger decrease in FA than pati ents with the lowest AP 
exposure (See supplemental Table 1).
Whole-brain group diff erences in mean FA at follow-up
There was a signifi cant associati on between group and FA at follow-up (χ2: 10.0, df=2, 
p=0.007): siblings (B= -0.007, p=0.03) and pati ents (B= -0.010, p=0.005) showed a sig-
nifi cantly lower mean FA compared to the controls. The sibling – pati ent comparison 
was neither large nor signifi cant (B=-0.001, p=0.46) (Fig. 1).
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Supplemental Table 1. Associations between group and ΔFA based on AP medication subgroups
Antipsychotics Between-group 
effect
Patient-Control Sibling-Control Sibling-Patient
(χ2, df=2, P) (B, P) (B, P) (B, P)
Lifetime exposure
Low (n=15) 6.1, 0.05 -0.0009, 0.66 -0.004, 0.03* -0.003, 0.16
Moderate (n=15) 5.2, 0.08 -0.003, 0.22 -0.003, 0.04* -0.001, 0.66
High (n=15) 8.7, 0.01 -0.005, 0.02* -0.004, 0.03* 0.001, 0.46
Last 3-years exposure
Low (n=18) 9.9, 0.007 0.002, 0.34 -0.004, 0.04* -0.006, 0.007*
Moderate (n=18) 6.5, 0.04 -0.004, 0.10 -0.004, 0.04* 0.0002, 0.93
High (n=17) 13.8, 0.001 -0.007, 0.004* -0.004, 0.03* 0.004, 0.07
Results from the association between group status and ΔFA, using patient subgroups (with low, 
moderate, high AP exposure). The χ2 and the P-values represent the significant results of the 
between-group factor analyses (P<0.05). Individual group comparisons are shown (B, P-value, 
P<0.05). Analyses are controlled for age, sex, handedness, level of education, and scan interval. 
Discussion
This longitudinal DTI study showed a relatively stable whole-brain mean FA course in 
patients with schizophrenia after the critical phase (ie, >5 years of illness duration), 
whereas a significant decline in mean FA was observed in siblings. The effect of group 
varied as a function of region, as indicated by a significant group by region interaction. 
Overall, there were more tracts showing a decrease than an increase over time in both 
patients and siblings, with a significant group difference in four white matter tracts.
Findings in patients
The study showed that, over a three-year period, the overall mean FA remained sta-
ble in patients, being continuously lower than the mean FA of controls and siblings. 
This data is partly in line with the results of the study by Mitelman and colleagues 
(2009), examining an older (than the present) sample (of ± 41 years) of patients with 
a diagnosis of schizophrenia and healthy controls, also showing a rather stable FA 
in patients, and a greater, probably normal age-dependent, FA decline over time in 
frontal, temporal and parietal white matter in healthy controls 20.
The results suggest that major white matter alterations in patients may have oc-
curred in the early stages of the illness, as described previously 15, without ongoing 
progression. Alternatively, WM may have been modulated by AP medication, which 
was supported in the current study by the small but significant negative within-group 
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effect of AP medication on ΔFA, with a dose-response effect for AP exposure over the 
last three years. Moreover, patients with the highest AP exposure levels (lifetime, as 
well as over the last three years) had a significant decrease in FA over time compared 
to controls, whereas this was not the case for patients with low or moderate AP expo-
sure compared to controls.
Together with the widespread microstructural WM alterations presented in cross-sec-
tional studies of at-risk populations and first episode psychotic patients 5, the data add 
to the evidence for an early developmental origin of WM alterations in schizophrenia 
8. Indeed, a significant progressive reduction in FA of the left frontal white matter has 
been found in UHR subjects who later developed psychosis compared to UHR subjects 
who did not make the transition 17.
Despite the overall mean FA being constant, most WM tracts in the three groups 
showed minor (non-significant) changes in individual FA trajectories (Table 2). White 
matter tracts develop at different ages in different curvilinear patterns (inverted 
U-shape), with FA increases from the newborn period to adolescence, shows decele-
rated maturation until mid-adulthood and subsequently displays more rapid decline 
during old age 40, 41. The WM tracts of the controls in this study may be at the top of 
the normal age trajectory curve because of the proportionally equal number of WM 
tracts with an FA increase and decrease. In contrast, patients showed a higher number 
of WM tracts with FA decreases, suggesting an altered developmental pattern, i.e., an 
earlier than expected age-related decrease of WM. Specifically, a smaller FA increase 
in the RPIC and decrease in the PCR and the cingulum (all right-sided) was found in 
patients. These tracts have face-validity, as they are frequently described in relation 
to fronto-temporal disconnection in schizophrenia 4, 42.
Findings in siblings
This is the first longitudinal study showing whole-brain white matter alterations over 
time in a sample of healthy participants at higher than average risk for psychotic 
disorder (siblings of patients with psychotic disorder). At baseline, there was no 
significant difference in whole-brain mean FA between siblings and controls, whereas 
such a difference was apparent between siblings and patients 24. At follow-up, siblings 
showed a significant lower whole-brain mean FA with respect to the controls and the 
significant difference with patients was no longer apparent. The difference at follow-
up was confirmed by a significant FA decrease over time in siblings compared to 
controls, which was not observed in patients. At the level of individual tracts, almost 
2/3rd of the WM tracts in siblings revealed a decrease in FA over time, compared to 
the more balanced ratio of FA increases and decreases in the controls. Specifically, 
the left PTR and the right cingulum revealed a significant decrease of mean FA over 
time in siblings, whereas controls showed an increase. The PTR has previously been 
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associated with schizophrenia 15, 43, e.g. with impaired emotional self-awareness 44. 
To our knowledge subtle FA decreases in the PTR have only been associated with 
bipolar 45 but not psychosis liability. As mentioned before, all WM tracts have different 
maturational trajectories 46. The cingulum has one of the most prolonged maturation 
periods and reaches its peak FA only after 40 years of age 47. Given the mean age of 
34 years in the siblings and of 32 years in the patients, the earlier than expected FA 
decline may reflect disturbed WM maturation from an early age, suggesting a neuro-
developmental origin. Alternatively, it may suggest progression associated with illness 
vulnerability, though the findings in the patients did not support this.
Decreased anisotropy in the cingulum has also been described in several cross-
sectional studies in patients with schizophrenia 48, 49 and in the longitudinal study 
of Mitelman and colleagues (2009), where the left anterior cingulate gyrus was one 
of the two areas that showed a greater decline in FA in patients with schizophrenia 
compared to healthy participants 20. Regarding the present finding of a patient-control 
difference in this region, current and previous cross-sectional DTI findings 50 in siblings 
may be suggestive of a WM intermediate phenotype.
Clinically, WM alterations in (sub-)regions of the cingulum have been related to 
impairments in impulsivity 51 and executive functioning 52 as well as to positive and 
negative symptoms 53 in patients with schizophrenia. As mild cognitive alterations are 
present in non-affected relatives 54, 55, it may be hypothesized that subclinical expres-
sion of symptoms are associated with this white matter intermediate phenotype, 
which will be the topic of further investigation.
Methodological considerations
Although the present study has several strengths, such as the rather large sample 
size, the longitudinal design covering a three-year period, and the inclusion of both 
patients and their healthy siblings, there are some limitations that need to be taken 
into account when interpreting the results.
AP medication may have an effect on WM 15. Until now, only a handful of longitudinal 
diffusion studies have been published, examining (short-term) effects of AP medica-
tion on microstructural white matter (pre-post treatment measurements) 56-59. The 
results of the present study were supportive of an effect of (especially the highest) cu-
mulative medication exposure levels on FA change over time, both in within-patients 
analyses and in between-group analyses based on AP exposure subgroups (with 
one-third of the patients in each subgroup). However, as the FA change in siblings, 
who were not using AP medication, was also significantly different from controls, 
AP exposure may be one of the contributing factors of microstructural white matter 
alteration in patients with psychotic disorder.
Differential time-course of microstructural white matter
73
3
The same applies to drug use. The present study sample was not drug-free which 
may have influenced our results. Study results differ with respect to the potential 
influence of cannabis use on white matter alterations in patients with schizophrenia 
60. Although the significant results in the control–sibling comparison remained stable 
after controlling for cannabis use (last year), lifetime cannabis use appeared to exert 
some influence, although the effect size was not affected much.
Given the absence of: i) differences in alcohol consumption across groups, ii) other 
drug use in the controls and siblings, and iii) effects of other drug use on microstruc-
tural white matter in the baseline study 24, sensitivity analyses for these substances 
were not considered additional informative.
Inconsistencies in the results of the limited longitudinal studies conducted to date 
may be due to varying patient samples 17, 20, as well as varying acquisition and ana-
lysing techniques. Although Reis Marques and colleagues (2012) used TBSS, their 
procedures and analyses differed from the present study 18. Furthermore, limited 
knowledge is available about the margins of across-session reproducibility errors 61, 62. 
As this was the first longitudinal DTI study including healthy siblings, we used a whole-
brain, voxel-based analyses, given the fact that evidence for differential WM regional 
time-trajectories is missing to date. The results of the group by region interactions 
are thus hypothesis-generating and may be of use in future longitudinal studies that 
examine individual WM tracts within distinct development trajectories.
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Abstract
Background. Decreased white matter (WM) integrity in patients with psychotic disor-
der has been a consistent finding in diffusion tensor imaging (DTI) studies. However, 
most studies are cross-sectional, and do not inform on the time course and the contri-
bution of environmental risk factors on these WM changes, which is what the current 
study set out to do.
Methods. DTI scans were obtained from 85 patients with a psychotic disorder, 93 
non-psychotic siblings and 80 healthy controls, of which 60% were rescanned 3 years 
later. In a whole-brain voxel-based analysis, associations between change in fractional 
anisotropy (∆FA) and environmental exposures (cannabis use and childhood trauma 
exposure) as well as interactions between group and environmental exposure in the 
model of FA and ΔFA were investigated. Analyses were adjusted for a priori hypothe-
sized confounding variables: age, sex, and level of education.
Results. At baseline no significant associations were found between FA and both 
environmental risk factors. At follow-up as well as over a 3-year interval, significant 
interactions between group and respectively cannabis exposure and trauma exposure 
in the model of FA and ΔFA were found. Patients showed more FA decrease over time 
compared to both controls and siblings when exposed to higher levels of cannabis or 
childhood trauma.
Conclusion. Higher levels of cannabis or childhood trauma may compromise connec-
tivity over the course of the illness in patients, but not in individuals at low or higher 
than average genetic risk for psychotic disorder, suggesting interactions between the 
environment and illness-related factors.
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Introduction
Reduced fractional anisotropy (FA), widely reported in patients with psychotic disor-
der 1, but not in individuals at higher than average genetic risk (siblings of patients) 
may reflect disease-related dysconnectivity or disease-related differential sensitivity 
to the environment 2, 3. The risk for psychosis, a condition with adolescent onset, has 
been related to environmental exposures such as pre- or postnatal birth complicati-
ons, cannabis use, early life trauma and growing up in an urban environment 4. These 
environmental stressors may be the trigger 5 or the “second hit” 6, contributing to the 
emergence of a psychotic illness. However, the potential impact of these environmen-
tal risks on white matter (WM) connectivity 7, 8 has not been the subject of detailed 
investigation in patients with a psychotic disorder. Cross-sectional studies did explore 
genetic factors, showing a moderate to high heritability of WM FA, ranging from 0.4 
– 0.7 9. Also, several candidate genes for WM heritability have been proposed, such 
as neuregulin1-tyrosine kinase receptor ErbB4 (NRG1-ErbB4), involved in oligoden-
drocyte, myelin and axonal development and maintenance 10. Various hypotheses 
have been postulated, associating environmental risk factors with WM alterations. 
Cannabis use may induce apoptosis of oligodendrocyte progenitors, affecting WM 
development 11. In the literature to date, there is evidence to suggest a negative as-
sociation between cannabis use and WM volume in patients with schizophrenia 12, 
13. Results from diffusion tensor imaging (DTI) studies are less clear and have shown 
increased as well as decreased FA in cannabis-using versus non-using patients with 
schizophrenia 14, 15. The same ambiguity is seen in samples of non-psychotic substance 
users compared to non-users, which, on the one hand, showed microstructural WM 
alterations in specific pathways (corpus callosum and superior longitudinal fascicules) 
16 and the hippocampus (fimbriae), corpus callosum (splenium), commissural fibres 17, 
as well as, on the other hand, absence of FA differences 18.
Studies on early life stress in otherwise healthy children have shown associations 
between cortisol reactivity and possible alterations in hippocampal and amygdala 
volumes 19. Corticosteroids may suppress the final mitosis of glial cells necessary for 
myelination, influencing WM microstructure 20. This model is supported by studies 
showing reduced corpus callosum volume in paediatric inpatients with a history of 
abuse and neglect 21 and reduced FA in the left inferior longitudinal fasciculus (ILF) in 
young adults witnessing domestic violence in childhood 22. To date, longitudinal diffu-
sion weighted imaging (DWI) studies of patients with schizophrenia are scarce 23 and 
apart from studies investigating the effect of medication on WM diffusion measures 24, 
25, no study has examined whether traumatic experience has a differential effect on FA 
over time in individuals with or without (liability for) psychotic disorder.
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In a cross-sectional analysis of the baseline DTI scans of the current sample, patient-
specific microstructural WM alterations were found 2. These alterations remained 
relatively stable over a 3-year time course in contrast to a decline in mean FA in the 
non-affected siblings compared to healthy controls 26. Consequently, both patients 
and siblings had decreased FA with respect to controls at follow-up. The aim of the 
current investigation was to study whether microstructural alterations over time were 
conditional on the exposure to two environmental risk factors for schizophrenia. More 
specifically, we hypothesized that individuals at increased genetic risk (patients and 
siblings) with higher levels of exposure to cannabis and childhood trauma would show 
reduced WM FA over time.
Methods
Participants
Subjects were recruited in the context of a multicentre longitudinal study (Genetic 
Risk and Outcome of Psychosis, G.R.O.U.P.) in the Netherlands 27. At baseline, 300 
participants were included of which 258 underwent a DTI scan. At follow-up, approxi-
mately three years later (mean: 3.3 years), DTI scans were acquired from a sample of 
180 participants, of which 159 provided a valid pair of DTI scans for the longitudinal 
analysis (see Domen et al. (2013, 2016) and the supplemental method section for 
further information on in- and exclusion criteria, family composition and diagnostic 
assessments) 2, 26.
The standing ethics committee approved the study protocol, and all participants gave 
written informed consent in accordance with the committee’s guidelines.
Measures
Level of psychotic symptomatology at the time of scanning was assessed with the 
Positive and Negative Symptom Scale (PANSS) 28.
Educational level was defined as highest accomplished level of education. Handed-
ness was assessed using the Annett Handedness Scale 29.
AP medication
The determination of (lifetime) antipsychotic (AP) medication use at baseline and 
cumulative AP exposure during the 3-year follow-up period has been described in the 
Supplemental Method section based on Domen et al., 2013 2, 2016 26.
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Substance use
Substance use was measured at both time points with the Composite International 
Diagnostic Interview (CIDI) sections B-J-L 30. As data of drug use of the last 3 years was 
not available, use of cannabis and other drugs was assessed as reported frequency 
of use during the last 12 months, as well as lifetime use (mean number of times 
until baseline measurement). CIDI frequency data on alcohol (weekly consumptions), 
lifetime cannabis and other drug use was available at follow-up for respectively 158 
participants (1% missing data), 155 participants (3% missing data) and 157 partici-
pants (1% missing data).
Developmental trauma
Developmental trauma was assessed at baseline with the Dutch version of the Child-
hood Trauma Questionnaire Short Form (CTQ). The short CTQ consists of 25 items 
rated on a 5-point Likert scale (1=never true to 5=very often true) inquiring about 
traumatic experiences in childhood. Five types of childhood maltreatment were as-
sessed: emotional, physical and sexual abuse, and emotional and physical neglect, 
with five questions covering each type of trauma 31. The mean of these 25 items 
(range: 5.0 – 25.0) created a general measure of developmental trauma. The CTQ 
data were missing for 1 patient.
Image acquisition
Magnetic resonance imaging scans were obtained at Maastricht University, the Ne-
therlands, using an Allegra Magnetom MR (Siemens, Erlangen, Germany) operating 
at 3.0 Tesla. At both measurement points, microstructural anatomy was examined 
using diffusion tensor imaging with an echo-planar-imaging sequence (field of view 
230 × 230 mm2, TR 10800 ms, TE 84 ms, voxel size 1.8 × 1.8 × 1.8 mm³, b-value 1000 
s/mm², 85 slices, no overlap). As a result of an update of the scanner software during 
baseline acquisition, two DTI sequences were used: one with 76 directions (of which 
four T2-weighted (B0) and 72 diffusion-weighted (B1000)) and one with 81 directions 
(8×B0 and 73×B1000). Gradient directions were identical in both sequences. A poten-
tial association between the proportion of baseline scans and group was investigated 
using a Pearson chi-square test.
At follow-up, the DTI sequence comprised 81 directions (8×B0 and 73×B1000). Total 
acquisition time of the DTI sequence was 15 minutes.
Diffusion tensor imaging analysis
Processing of DTI data was performed using tract-based spatial statistics (TBSS) v1.2 
in FSL 4.1.6 (FMRIB Analysis Group, Oxford, UK, http://www.fmrib.ox.ac.uk/analysis/
research/tbss). The consecutive processing steps until the nonlinear transformation 
Trauma- and cannabis-associated microstructural white matter changes in psychosis
85
4
of the FA volumes into standard space are described in the Supplemental Method 
section (based on Domen et al., 2013 2, 2016 26). For the current study, three mean FA 
skeletons were created; for the cross-sectional analysis at baseline (n=258: controls, 
siblings, patients) and at follow-up (n=180) and, for the longitudinal analysis, one 
based on six groups (3 groups × 2 time-points). The mean FA skeleton follows the 
major WM tracts in each individual participant (normalized in MNI152 space) and 
provides a way to compare between (groups of) participants. The FA threshold was 
set, using visual inspection of the FA skeleton, at a level of 0.25, to include major WM 
tracts whilst removing small peripheral tracts that would cause excess inter-partici-
pant variability. In addition, this threshold setting avoided inclusion of regions that are 
likely to be composed of multiple tissue types or fibre orientations. In the final step, 
a binary skeleton mask of the individual participants was created and used to extract 
FA values of most large WM tracts (n=38) in order to create a whole-brain mean FA 
for the subsequent statistical analyses. The Johns Hopkins University International 
Consortium for Brain Mapping (JHU ICBM)-DTI-81 white-matter atlas labels 33 and the 
JHU white-matter tractography atlas 34 were used to identify and assign a specific tract 
name to as much voxels as possible.
Statistical analyses
In order to use a multilevel (mixed-effects) model and to be able to calculate a mean 
FA “change” (mean FA at baseline minus mean FA at follow-up) for the longitudinal 
model, which was not compatible with the standard protocol in TBSS, data were ana-
lysed in R (version 3.2.0), a free software environment for statistical computing and 
graphics 35. From the 38 labelled WM tracts, skeleton mean FA values per participant 
per time point were extracted and exported to R. Since the mean FA values per subject 
were based on varying number of voxels, depending on the region, we used a model 
in which the error variance for a particular observation was inversely weighted by the 
number of voxels within the corresponding region.
Cross-sectional analysis at baseline and follow-up
To examine cross-sectional associations between the environmental exposures 
(lifetime and last year cannabis use, childhood trauma) and whole-brain mean FA at 
baseline (n=258) and at follow-up (n=180), the data set was transformed from a wide 
to a long format, resulting in a hierarchically structured data set, based on 38 regional 
mean FA measures (Level 1) nested in subjects (Level 2) who were part of the same 
families (Level 3). Because of the three-level grouping structure of the data, com-
promising statistical independence of the observations, a multilevel (mixed-effects) 
model was fitted. FA was the dependent variable, group (dummy variables with the 
controls as the reference category, controls = 0, siblings = 1, patients = 2,) and the 
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environmental exposures (lifetime and last year cannabis exposure, trauma exposure) 
were the independent variables and random effects (intercepts) were added for both 
subject and family.
The statistical basic model was: FA= β0 + β1 (group) + β2 (environmental exposure) + 
β3 (group × environmental exposure). This model included the a priori hypothesized 
confounding variables age, sex, and level of education as fixed effects. In case of 
significant findings, additional confounding variables: Body Mass Index (BMI), alcohol 
consumption, and lifetime other drug use were separately added.
Main effects of the environmental exposures (controlled for group), as well as group 
× environmental exposures interactions in the model of FA were examined. The 
environmental exposures were entered both as linear and as factored variables (i.e. 
representing the distribution of scores divided by its tertiles: lifetime cannabis use: 
no, moderate or heavy cannabis use; childhood trauma exposure: low, moderate, or 
high trauma exposure), allowing visualization of dose–response. In case of significant 
interaction effects, stratified analyses were conducted in order to quantify whether 
the association between environmental exposure and FA differed between the three 
groups.
To examine whether childhood trauma and lifetime cannabis use contributed inde-
pendent effects, planned sensitivity analyses were performed with both environmen-
tal exposures in the model.
To examine whether the scanner software update at baseline affected the results, the 
interaction analyses at baseline were repeated in subgroups stratified by the number 
of scan directions: 76 (n=191) vs. 81 (n=67) directions.
Longitudinal analysis
A mean FA “change” (delta, Δ) per participant per region (n=159) was calculated by 
subtracting mean FA at baseline from mean FA at follow-up. The same procedure, 
basic statistical model and analyses were applied as described in the cross-sectional 
part, now using ΔFA as the dependent variable and group and the environmental 
exposures (lifetime and last year cannabis exposure, trauma exposure) as the inde-
pendent variables.
In case of a significant group effect for whole-brain mean ΔFA, a region-of-interest 
(ROI) analysis was performed, examining group × environmental exposure (linear 
variable) interactions in four WM tracts: left posterior thalamic radiation (PTR), right 
retrolenticular part of the internal capsule (RPIC), right cingulum, and right posterior 
corona radiate (PCR). These WM tracts were chosen because they showed, in the 
current study population, a significant group difference in ΔFA 26, and they have been 
associated with cannabis use and childhood trauma in human and animal studies 
14, 36-39. In addition, to control for a potential effect of depression on ΔFA, the main 
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longitudinal analysis was repeated with exclusion of the subgroup of participants in 
the control (n=11) and sibling group (n=15) with a history of a depressive disorder.
Since our previous study showed a small effect of last 3-year and lifetime antipsychotic 
(AP) use on ΔFA 26, planned sensitivity analyses were performed to rule out potential 
AP effects, using patient subgroups (with low, moderate and high AP exposure (for 
the number of participants per subgroup see Supplemental Table)). Thus, the group × 
environmental exposure interactions in the model of ΔFA were examined in three AP 
subgroup to ascertain whether a potential effect remained significant in the respec-
tive subgroups.
Results
Demographics
The patients represented a relatively stable population (not in need of inpatient care 
or intensive treatment), as reflected by the low PANSS scores and the number of 
patients that fulfilled the remission criteria (Table 1). The gender distribution in the 
samples was skewed, showing more male patients and male siblings as high cannabis 
users and more male patients and female controls exposed to high levels of childhood 
trauma at follow-up (Table 2). The mean current dosage of AP medication in terms of 
standard haloperidol equivalents was 5.5 milligrams (mg) (SD = 4.6) at baseline and 
4.7 mg (SD = 5.1) at follow-up (over the last 3 years). The proportion of baseline scans 
with 76 directions did not differ between the groups (84% in controls, 82% in siblings, 
and 71% in patients: χ2= 3.02, df = 2, P = .22).
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Table 2. Within-group distribution of the environmental exposures
Cannabis use Childhood trauma
baseline follow-up m/f ratio baseline follow-up m/f ratio
Controls
no (low) 2204 (73%) 1406 (76%) 38/62 1444 (48%) 798 (43%) 52/48
medium 304 (10%) 190 (10%) 40/60 988 (32%) 684 (37%) 28/72
high 494 (17%) 266 (14%) 43/57 608 (20%) 380 (20%) 30/70
Siblings
no (low) 2242 (64%) 1330 (64%) 49/51 1368 (39%) 874 (42%) 52/48
medium 418 (12%) 228 (11%) 33/67 1292 (36%) 684 (33%) 59/41
high 836 (24%) 532 (25%) 71/29 874 (25%) 532 (25%) 43/57
Patients
no (low) 1178 (39%) 760 (39%) 60/40 798 (25%) 646 (31%) 53/47
medium 228 (8%) 190 (10%) 20/80 836 (26%) 570 (27%) 80/20
high 1634 (53%) 988 (51%) 88/12 1558 (49%) 874 (42%) 83/17
The number of observations (=number of subjects × number of regions (38)) per group (and 
proportion of total group) for the baseline (n=258) and longitudinal analysis (n=159) per 
environmental stress factor
m/f ratio, male/female ratio at follow-up
Cross-sectional analysis of FA and environmental risk factors at baseline
There were no significant associations between cannabis exposure and FA (lifetime: 
B=0.002, P=0.24, last year: B=1.0×10-5, P=0.43) or between trauma exposure and FA 
(B=-0.001, P=0.60). In addition, no significant interactions were found between can-
nabis exposure and group in the model of FA (lifetime: χ2=1.3, df=2, p=0.52, last year: 
χ2=0.1, df=2, p=0.93) and between trauma and group in the model of FA (χ2=2.9, df=2, 
p=0.24) (all analyses with linear environmental variables). The results did not change 
after stratification by number of scan directions (76 directions: cannabis exposure; 
lifetime: χ2=1.4, df=2, p=0.49, last year: χ2=0.2, df=2, p=0.89, trauma exposure: χ2=2.3, 
df=2, p=0.31; and 81 directions: cannabis exposure; lifetime: χ2=1.2, df=2, p=0.56, last 
year: χ2=1.5, df=2, p=0.48, trauma exposure: χ2=0.2, df=2, p=0.93).
Cross-sectional analysis of FA and environmental risk factors at follow-up
No significant associations between cannabis exposure (linear variable) and FA (life-
time: B=1.0×10-4, P=0.95, last year: B=-3.0×10-6, P=0.88) or between trauma exposure 
(linear variable) and FA (B=-0.001, P=0.67) were found at follow-up.
Cannabis
No significant interaction was found between last year cannabis use and group in 
the model of FA (χ2=0.8, df=2, p=0.66). A significant interaction was found between 
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respectively (lifetime) cannabis exposure (χ2=9.3, df=2, p=0.01) and group in the 
model of FA. This interaction remained significant after controlling for childhood 
trauma (χ2=9.6, df=2, p=0.008), BMI (χ2=9.7, df=2, p=0.008), alcohol use (χ2=9.8, df=2, 
p=0.008), and other drug use (χ2=7.6, df=2, p=0.02) (all linear variable).
Stratified analyses showed a mean FA decrease in the heavy cannabis using patients, 
which was significantly different from the controls and the siblings. An association in 
opposite direction was found in cannabis-using siblings, but only for the moderate 
cannabis exposure level and not for the highest exposure level (See Table 3).
Trauma
A significant interaction between trauma exposure and group in the model of FA 
(χ2=6.1, df=2, p=0.05) was found. The interaction remained significant after controlling 
for alcohol use (χ2=8.8, df=2, p=0.01), trend-significant after controlling for lifetime 
cannabis use (χ2=4.9, df=2, p=0.09) and BMI (χ2=5.5, df=2, p=0.06), though was not 
significant after addition of other drug use (χ2=4.4, df=2, p=0.11) (all linear variable).
Stratified analyses showed a mean FA decrease in patients exposed to a high child-
hood trauma level, which was significantly different from the siblings and trend- sig-
nificantly different from the controls (See Table 3).
Longitudinal analysis of ΔFA and environmental risk factors
In the whole group, there was no significant association between respectively lifetime 
cannabis exposure (B=-3.0×10-5, P=0.16), last year cannabis exposure (B=-1.0×10-5, 
P=0.45) or trauma exposure (all linear variable) and ΔFA (B=-7.0×10-4, P=0.13).
Cannabis
There was a significant interaction between (lifetime) cannabis exposure and group 
in the model of ΔFA (χ2=6.2, df=2, p=0.04). This interaction remained significant after 
controlling for childhood trauma (χ2=5.9, df=2, p=0.05), BMI (χ2=5.8, df=2, p=0.05), 
alcohol use (χ2=5.9, df=2, p=0.05), other drug use (χ2=7.4, df=2, p=0.02), and scan 
type (χ2=6.5, df=2, p=0.04). After exclusion of the 26 participants with a history of 
depression (16% reduction in sample size), the interaction became trend-significant 
(χ2=5.4, df=2, p=0.07) (all linear variable).
Stratified analyses showed a significant effect in patients, indicating a decrease in 
FA over time with increasing cannabis exposure in patients, resulting in a significant 
group difference between patients and controls and between patients and siblings. 
Compared to patients with no cannabis use, patients with heavy cannabis consump-
tion had significantly more FA decrease over time. This was not the case for the 
moderate versus no cannabis use comparison (Table 4, Fig. 1).
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A
Fig. 1. The associati on between respecti vely cannabis (A) and childhood trauma (B) (dummy 
variables) and ΔFA, strati fi ed per group. The eff ect of high cannabis exposure vs. no cannabis 
exposure and high trauma exposure vs. low trauma exposure on mean whole brain ΔF was 
signifi cantly diff erent for pati ents compared to controls (cannabis; χ2=3.7, p=0.05, trauma; 
χ2=10.0, p=0.002) and for pati ents compared to siblings (cannabis; χ2=4.3, p=0.04, trauma; χ2=7.2, 
p=0.007) (*p<0.05).
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Table 4. Mean ΔFA as a function of group status and environmental exposure
Environmental exposure Patients Siblings Siblings Controls Group differences
N ΔFA B P N ΔFA B P N ΔFA B P χ2 P
Lifetime Cannabis
Cannabis (linear) -0.003 0.02* 0.001 0.41 0.001 0.39 P vs. C 4.1 0.04*
P vs. S 4.7 0.03*
S vs. C 0.03 0.87
No cannabis use a 20 0.0014±0.03 35 -0.0040±0.03 37 -0.0005±0.03
Moderate cannabis use 5 0.0038±0.03 0.002 0.60 6 0.0003±0.03 0.004 0.25 5 0.0040±0.03 0.003 0.47 P vs. C 0.02 0.90
P vs. S 0.1 0.71
S vs. C 0.1 0.80
Heavy cannabis use 26 -0.0041±0.03 -0.006 0.02* 14 -0.0022±0.03 0.002 0.51 7 0.0040±0.03 0.002 0.47 P vs. C 3.7 0.05*
P vs. S 4.3 0.04*
S vs. C 0.03 0.86
Childhood trauma
Trauma (linear) -0.004 0.0005* 0.0002 0.90 0.002 0.26 P vs. C 9.7 0.002*
P vs. S 6.4 0.01*
S vs. C 0.6 0.45
Low trauma a 17 0.0034±0.03 23 -0.0018±0.03 21 -0.00003±0.03
Medium trauma 15 0.0016±0.03 -0.002 0.42 18 -0.0068±0.03 -0.003 0.17 18 -0.00002±0.03 0.0008 0.75 P vs. C 0.7 0.42
P vs. S 0.1 0.76
S vs. C 1.4 0.24
High trauma 23 -0.0060±0.03 -0.009 0.0005* 14 -0.0004±0.03 0.001 0.71 10 0.0031±0.03 0.004 0.23 P vs. C 10.0 0.002*
P vs. S 7.2 0.007*
S vs. C 0.4 0.50
a Reference level
P vs. C = patients vs. controls; P vs. S = patients vs. siblings; S vs. C = siblings vs. controls, 
ΔFA: means and SD are reported. 
Results from the interaction: environmental exposure × group in the model of ΔFA. The B’s 
represent the stratified group effect sizes. Group differences are displayed with χ2, and the P-value 
(<0.05*).
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Table 4. Mean ΔFA as a function of group status and environmental exposure
Environmental exposure Patients Siblings Siblings Controls Group differences
N ΔFA B P N ΔFA B P N ΔFA B P χ2 P
Lifetime Cannabis
Cannabis (linear) -0.003 0.02* 0.001 0.41 0.001 0.39 P vs. C 4.1 0.04*
P vs. S 4.7 0.03*
S vs. C 0.03 0.87
No cannabis use a 20 0.0014±0.03 35 -0.0040±0.03 37 -0.0005±0.03
Moderate cannabis use 5 0.0038±0.03 0.002 0.60 6 0.0003±0.03 0.004 0.25 5 0.0040±0.03 0.003 0.47 P vs. C 0.02 0.90
P vs. S 0.1 0.71
S vs. C 0.1 0.80
Heavy cannabis use 26 -0.0041±0.03 -0.006 0.02* 14 -0.0022±0.03 0.002 0.51 7 0.0040±0.03 0.002 0.47 P vs. C 3.7 0.05*
P vs. S 4.3 0.04*
S vs. C 0.03 0.86
Childhood trauma
Trauma (linear) -0.004 0.0005* 0.0002 0.90 0.002 0.26 P vs. C 9.7 0.002*
P vs. S 6.4 0.01*
S vs. C 0.6 0.45
Low trauma a 17 0.0034±0.03 23 -0.0018±0.03 21 -0.00003±0.03
Medium trauma 15 0.0016±0.03 -0.002 0.42 18 -0.0068±0.03 -0.003 0.17 18 -0.00002±0.03 0.0008 0.75 P vs. C 0.7 0.42
P vs. S 0.1 0.76
S vs. C 1.4 0.24
High trauma 23 -0.0060±0.03 -0.009 0.0005* 14 -0.0004±0.03 0.001 0.71 10 0.0031±0.03 0.004 0.23 P vs. C 10.0 0.002*
P vs. S 7.2 0.007*
S vs. C 0.4 0.50
a Reference level
P vs. C = patients vs. controls; P vs. S = patients vs. siblings; S vs. C = siblings vs. controls, 
ΔFA: means and SD are reported. 
Results from the interaction: environmental exposure × group in the model of ΔFA. The B’s 
represent the stratified group effect sizes. Group differences are displayed with χ2, and the P-value 
(<0.05*).
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In the ROI analyses, no significant interactions were found between cannabis expo-
sure and group in the model of ΔFA, except for the right cingulum, but the stratified 
analyses did not reach significance (Table 5).
Table 5. Group × environmental exposure in the model of mean ΔFA in four WM tracts
Brain Region Between-
group effect
Patients Siblings Controls Group differences
(χ2, df=2, P) (B, P) (B, P) (B, P) (χ2, P)
LT Cannabis use
RPIC, right 1.3, 0.52 - - - -
PCR, right 0.9, 0.63 - - - -
Cingulum, right 6.1, 0.05* -0.01, 
0.10
0.01, 
0.19
0.01, 
0.19
P vs. C: 4.1, 0.04
P vs. S: 4.5, 0.03
S vs. C: 0.04, 0.84
PTR, left 1.5, 0.48 - - - -
Childhood trauma
RPIC, right 10.3, 0.006* -0.01, 
0.02*
0.01, 
0.04*
-0.002, 
0.71
P vs. C: 1.4, 0.23
P vs. S: 10.3, 0.001*
S vs. C: 2.4, 0.12
PCR, right 2.5, 0.28 - - - -
Cingulum, right 10.5, 0.005* -0.02, 
0.0002*
0.005, 
0.43
0.005, 
0.48
P vs. C: 3.6, 0.06
P vs. S: 10.3, 0.001*
S vs. C: 1.1, 0.30
PTR, left 3.7, 0.15 - - - -
Results from multilevel modelling: the χ2 and the P-values represent the significant results of the 
group × environmental exposure in model of ΔFA per WM tract (*P<0.05). Group differences per 
WM tract are shown (χ2, P-value, *P<0.05). Analyses are controlled for age, sex, level of education, 
and scan interval.
LT=Lifetime, P vs. C = patients vs. controls; P vs. S = patients vs. siblings; S vs. C = siblings vs. controls, 
RPIC=Retrolenticular part of internal capsule, PCR=Posterior corona radiata, PTR=Posterior 
thalamic radiation
Trauma
A significant interaction between trauma exposure and group in the model of ΔFA 
(χ2=11.3, df=2, p=0.003) was found. The interaction remained significant after control-
ling for lifetime cannabis use (χ2=12.3, df=2, p=0.002), BMI (χ2=10.5, df=2, p=0.005), 
alcohol use (χ2=12.0, df=2, p=0.003), other drug use (χ2=14.6, df=2, p=0.0007), and 
scan type (χ2=11.5, df=2, p=0.003). The interaction was nearly significant after ex-
clusion of the 26 participants with a history of depression (χ2=5.6, df=2, p=0.06) (all 
linear variable).
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Stratified analysis revealed a significant negative association between trauma and ΔFA 
in patients, resulting in a significant patient – control and patient – sibling difference. 
Compared to low trauma exposure, patients exposed to high trauma levels had signi-
ficantly more FA decrease over time. This was not the case for moderate compared to 
low trauma exposure (Table 4, Fig. 1).
In the ROI analysis, two of the four WM tracts showed significant interactions bet-
ween trauma exposure and group in the model of ΔFA: the right RPIC and the right 
cingulum. In the right RPIC, higher trauma levels were significantly associated with 
more FA decrease in patients and with more FA increase in siblings. The slopes were 
significantly different for the patient-sibling comparison, but not for the patient-
control and sibling-control comparison. In the right cingulum, a significant negative 
association between trauma and ΔFA was found in patients only, resulting in a bor-
derline significant patient-control and a significant patient-sibling difference (Table 5).
Sensitivity analyses in AP medication subgroups
The interactions between both environmental risk factors and group in the model of 
ΔFA were partly significant in the AP medication subgroup analyses (with smaller N), 
most prominent in patients with the lowest (lifetime & 3-year interval) AP exposure 
levels (See Supplemental Table 1).
Discussion
Despite absence of cross-sectional associations between environmental risk factors 
and WM fractional anisotropy at baseline, there were significant interactions bet-
ween group and cannabis and trauma exposure in models of FA at follow-up and FA 
change over a 3-year time period. Patients exposed to the highest levels of cannabis 
or childhood trauma had a greater FA decrease over time compared to controls and 
siblings. ROI analysis revealed that the patient-related effect of childhood trauma 
exposure was especially apparent in the right cingulum.
Cannabis exposure and white matter alterations
Higher levels of (lifetime) cannabis exposure in patients with psychotic disorder were 
not associated with FA alterations at baseline, but with significant FA reduction over a 
3-year period compared to siblings and healthy controls. This is the first longitudinal 
study examining the effect of cannabis on WM FA in relation to (familial risk for) 
psychotic disorder, suggesting that the extent of WM alterations is conditional on 
the level of cannabis exposure in patients with the disorder. Especially, cannabis use 
before or at disease-onset may cause an additional reduction in WM FA, given the 
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absence of an interaction between group and last year cannabis use in the model of 
ΔFA. This finding complies with other structural imaging findings of more severe WM 
deficits in young adults exposed to cannabis prior to the age of 16 40. It strengthens 
the evidence, from both preclinical human and animal models, for a neurotoxic effect 
of cannabis in adolescence 41; a sensitive age-period for the neuronal maturation of 
the endocannabinoid system, possibly resulting in disrupted network connectivity of 
various brain areas.
To date, three longitudinal DTI studies examined substance abuse in non-psychotic 
populations. Reduced longitudinal FA increase was found in adolescent cannabis users 
(n=23) in 5 clusters of fronto-parietal association fibers over a 2-year interval 42, as 
well as a significant FA decrease over time in the left ILF in adolescents with cannabis 
use disorder (n=19), associated with more cannabis exposure, compared to healthy 
controls 43. After an 18-month follow-up, poorer WM integrity was reported, although 
mainly predicted by alcohol, not marijuana in 7 fronto-parietal tracts in adolescent 
substance users (n=41) 36.
In previous cross-sectional studies, positive as well as negative associations between 
FA and cannabis use in patients with schizophrenia have been reported. James and 
colleagues (2011) revealed associations between early cannabis use and decreased 
FA in e.g. the internal capsule, corona radiata, superior and ILF, in patients with 
adolescent-onset schizophrenia 14. In contrast, Peters and colleagues (2009) found 
FA increases in the bilateral uncinate fasciculus, anterior internal capsule, and frontal 
WM in patients with recent onset schizophrenia who had started using cannabis 
before the age of 17 years, compared to a similar group with no history of cannabis 
use 44. Reduced FA has also been found in the splenium of the corpus callosum in non-
cannabis using patients with schizophrenia compared to patients with schizophrenia 
and early onset cannabis use (before age 15 years) 45. It has been shown that cannabis 
use may have different effects at various neurodevelopmental stages of life 46. In the 
present study, absence of a significant cross-sectional association between FA and 
lifetime cannabis exposure at baseline in contrast to significant associations at follow-
up between respectively high and moderate cannabis exposure and FA in patients and 
siblings compared to controls may imply an age-related effect. The effect of cannabis 
on brain WM may only be detectable after many years, depending on the individual 
WM curvatures and the timing of the measurement.
The opposite direction of effect in siblings, i.e. the FA increase with higher lifetime 
cannabis exposure, may suggest a delayed maturation, an imaging artifact or even a 
protective effect of a small amount of cannabis. A cannabinoid neuroprotective effect 
on brain matter with improvement in WM efficiency 47 has been proposed by recent 
in vitro studies 48.
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The negative association between especially the heavy cannabis using patients with 
psychotic disorder and FA may fit with the hypothesis that heavy cannabis use at a 
young age may alter the normal trajectory of WM brain maturation. It may thus be 
hypothesized that interference with the extensive pruning and myelination processes 
in a vulnerable adolescent brain 49 and the interaction with illness-related factors may 
cause additional reduction in WM FA later in life. Whether this has clinical implications 
or influences long-term prognosis needs further investigation.
Childhood trauma exposure and white matter alterations
The present study examined the association between childhood trauma and FA in 
individuals with (risk for) psychotic disorder. At baseline, neither a significant inter-
action between trauma exposure and group in the model of FA was found, nor a 
main effect of trauma in any of the groups. However, at follow-up, a significant (dose-
response) negative association between trauma exposure and group in the model of 
FA was found in patients with psychotic disorder. In other words, higher exposure to 
childhood trauma is associated with lower whole-brain mean FA later in life. As with 
cannabis, differences in baseline and follow-up results may be explained by the timing 
of genetic and environmental influences (and their interactions) impacting cerebral 
plasticity during the life span.
The follow-up findings are in line with several studies that show reduced FA in non-
psychotic traumatized subjects 22, 50 in stress-processing related areas, such as the 
corpus callosum 51, 52 and the cingulum bundle 39, 53. Thus, cross-sectional studies 
indicate that the FA reductions in traumatized populations may show overlap with 
the WM abnormalities in schizophrenia 1, 54, suggesting that (part of) the WM tract 
alterations may be non-specific, contributing to different phenotypes.
The current study did also find a greater FA decline over a 3-year period in the pa-
tients with the highest level of childhood trauma exposure with respect to siblings 
and healthy controls. This significant FA decline over time associated with higher 
levels of childhood trauma may fit with the literature describing the neurotoxic 
impact of childhood trauma on WM development at a sensitive age-period 55. The 
present finding of FA decline over time in the right cingulum, which was associated 
with high childhood trauma exposure, is of interest as this tract is considered part of 
the stress-processing neurocircuitry, connecting key structures in the limbic system as 
the amygdala, hypothalamus, hippocampus and frontal structures (e.g. the anterior 
cingulate cortex) to the rest of the brain 56. It is also in line with a recent small study 
showing a negative association between adverse childhood experiences and FA (e.g. 
in the left cingulum) in patients with a diagnosis of schizophrenia, but this study did 
not include a control group 57.
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The present study also found a patient-sibling FA difference in the RPIC, but there was 
no difference with respect to controls. This WM tract has not previously been related 
to trauma, although increased mean diffusivity has been described in individuals at 
clinical high risk for psychosis 58 and in a subset of patients with schizophrenia expe-
riencing negative symptoms 59. The finding of a significant FA increase in siblings in this 
tract may be “chance” given the small subgroup of siblings with a history of childhood 
trauma, or it may be a biological marker of their resilience to environmental stressors.
The patient-specific finding with regard to trauma may refer to a complicated interplay 
between trauma-related factors and psychosis-related factors to account for the more 
pronounced WM alterations, predominantly in the group with the highest trauma 
exposure. Although a causal relationship between trauma and WM decreases cannot 
be determined from these data, experiencing severe childhood trauma may cause an 
additive effect on already disrupted WM development. Alternatively, illness-related 
factors such as disadvantageous life style and health issues (e.g. reduced physical 
activity, social deprivation, smoking) 60 may have contributed to increased cerebral 
vulnerability in patients, either or not in interaction with the environmental expo-
sures under investigation.
Methodological considerations
Apart from the strength of this study - a relatively large longitudinal imaging design 
with a gene-environment approach - some limitations need to be addressed.
The sample size of some longitudinal subgroup analyses was only modest or small, 
resulting in loss of power and increased likelihood of false-negative results. Taken 
together with a rather skewed gender distribution in our sample, gender specific sub-
analyses were not considered feasible although it is known that several WM tracts 
show gender-specific FA differences 61, 62.
Since the effect sizes in this study are small, full understanding of the biological and 
clinical relevance of the results is hampered. Nevertheless, one can imagine that 
disproportionally higher changes may arise due to stronger regional effects, either or 
not in combination with higher mean trauma levels. Future studies with larger sample 
sizes may provide more precise estimates of regional FA effect sizes associated with 
these environmental exposures.
Conform the various results across studies on the association between AP use and 
WM alterations 24, 25, 63, and the small effect of last 3-year and lifetime AP use on ΔFA 
found in our previous analyses 26, the current results suggest a minor confounding 
effect of AP use as not all the G x E interactions remained significant in different AP 
subgroups. However, the results of these sensitivity analyses must be viewed with 
caution given the sizable lack of power (patient-AP subgroups comprised of one-third 
of the sample).
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It is unlikely that the two DTI sequences used at baseline would have contributed to a 
systematic bias, as the proportions of the two sequences were almost equal between 
the groups. In addition, stratified analyses (by number of scan directions) and adjust-
ment for scanning sequence did not change the results, fitting the suggestion that 
the variation in tensor estimation is negligible with more than 30 diffusion directions 
64. Extracting mean FA values from the TBSS skeleton has the disadvantage of only 
examining the central portion of the WM tract, but will procure that WM was indeed 
examined. This is in line with more recent cannabis - diffusion studies that took a 
distance from a voxel-based comparison approach 46.
Lastly, FA is a rather non-specific diffusion measure, containing information on 
myelination, fibre organization and number of axons, and therefore not completely 
synonymous to ‘WM integrity’, so that the current findings must be interpreted with 
caution 65. Nonetheless, a whole-brain, hypothesis-generating approach was chosen, 
as studies investigating the influence of environmental risk factors on WM alterations 
in patients with psychotic disorder are scarce and ambiguous.
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In the present thesis, we examined microstructural white matter (WM) integrity 
cross-sectionally and longitudinally in patients with a psychotic disorder, unaffected 
siblings of patients with psychotic disorder and a healthy control group. Moreover, 
the role of environmental risk factors was assessed in relation to microstructural WM 
alterations (over time) and background psychosis-risk.
Intermediate phenotype
Investigating the etiology of a heterogeneous psychiatric syndrome as psychotic disor-
der is rather challenging, given the complex interaction between multiple candidate 
genes and an estimated modest effect of the environment 1. One of the goals of this 
thesis was to find a measurable WM brain alteration that is present in individuals at 
higher than average genetic risk for psychotic disorder (unaffected siblings), as an 
indication for a potential intermediate phenotype 2. A single intermediate phenotype 
associated with a single psychiatric disorder, however, is a too simplistic represen-
tation and certain intermediate phenotypes may reflect both the genetic as well as 
the environmental risk factor for a psychiatric disorder 3. It has also been proposed 
that the classic endophenotype concept in the context of psychotic disorder needs 
renewal, given the dynamic changes displayed in the different stages of the illness. 
Imaging data show inconsistent results of (brain) changes prior to the onset of psy-
chosis in clinical high-risk samples, in contrast to more solid grey and white matter 
findings during and after transition to psychotic disorder. Therefore, the study of early 
and late maturational processes via a longitudinal approach can help to identify these 
dynamic changes in the pre-onset stage, and subsequently may become incorporated 
into future endophenotype concepts 4.
White matter intermediate phenotype from a cross-sectional perspective
A recent qualitative review described various alterations in WM regions (e.g. left 
inferior longitudinal fasciculus, anterior limb of the internal capsule, corpus callosum, 
cingulum) in the relatives of patients with a psychotic disorder, with FA values being 
intermediate compared to the values of patients and controls 5. In the study presen-
ted in chapter 2, a potential WM diffusion intermediate phenotype was investigated 
using a whole-brain voxel-based analysis approach in a family based design. Analysis, 
using Tract Based Spatial Statistics (TBSS), showed widespread significantly lower 
mean fractional anisotropy (FA) (eg. the corpus callosum, forceps major and minor, 
posterior thalamic radiation bilaterally) in patients with psychotic disorder compared 
to unaffected siblings and healthy controls. In some regions, intermediate FA values 
were found in the unaffected siblings, yet siblings were not significantly different 
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from controls. These results are in line with the majority of the voxel-based analysis 
(VBA) studies with FA as main outcome measure, showing no significant FA decreases 
in unaffected siblings compared to healthy controls 6-13. Significant sibling - control 
differences were only found in two small VBA studies 14,15 and five regions-of-interest 
(ROI) studies 7,10,11,16,17 (including three of the already mentioned negative VBA studies, 
in which also an ROI approach was applied 7,10,11) (see Table 1). Taken into account all 
these DTI WM studies on unaffected siblings of patients with psychotic disorder, the 
literature is ambiguous, from which one may conclude that regional disrupted con-
nectivity, especially in the corpus callosum, may be an endophenotype for schizophr-
enia 5. On the other hand, the regional white matter brain pathology in the patients in 
combination with the absence of findings in relatives may fit the suggestion of illness 
and/or treatment-related alterations. A meta-analysis on this subject seems highly 
warranted.
White matter endophenotype from a longitudinal perspective
Given the fact that WM development shows a tract-specific, age-dependent curvilinear 
course, with increases into adolescence, decelerated maturation until mid-adulthood 
and after that a gradual decline 18, genetically sensitive longitudinal diffusion studies 
may be best suited to discover potential structural WM endophenotypes over the 
course of the illness. The results of the first longitudinal family-based diffusion study 
were presented in chapter 3. The main findings were: (i) a significant decline in whole 
brain mean FA in non-psychotic siblings of patients with psychotic disorder compared 
to controls and (ii) a fairly stable whole-brain mean FA in patients with a psychotic 
disorder over a 3-year period.
There were more tracts showing a decrease than an increase in FA over time in both 
patients and siblings. A significant smaller FA increase in the right retrolenticular part 
of the internal capsule (RPIC) and a FA decrease in the right cingulum in patients and 
siblings compared to controls was found. Furthermore, a significant decrease in FA of 
the right posterior corona radiata was found in patients compared to controls and a 
decrease in FA of the left posterior thalamic radiation (PTR) was found in siblings with 
respect to patients and controls.
As the effect sizes were small and as the period of investigation only covers a relatively 
short period during the illness trajectory, the biological significance and clinical rele-
vance need further investigation. Nevertheless, the findings provide information on 
the direction of WM FA change (increase, decrease, progression vs. static alterations) 
compared to a ‘typical age-trajectory’. Moreover, even small decreases in microstruc-
tural WM connectivity may have a profound effect on the topological organization of 
the connectome, and thus could result in reduced communication between segrega-
ted brain regions 19, 20.
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Table 1. Summary of DTI studies comparing unaffected relatives of patients with a psychotic 
disorder to controls
Analysis 
Method
Authors Sample
(Relatives–Controls)
Results
(FA: Relatives–Controls)
VBA Domen et al.8 93 - 80 No significant group differences in 
FA
Boos et al.6 123 - 109
Camchong et al.7 22 - 30
Goghari et al.9 24 - 27
Knochel et al.10 18 - 22
Munoz Maniega et 
al.11
22 - 51
Philips et al.12 49 - 21
Prasad et al.13 21 - 29
VBA Hao et al.14 34 - 32 In relatives:
- FA↓: left hippocampus, left 
prefrontal cortex
Hoptman et al.15 22 - 37 In relatives:
- FA↓: WM of the left inferior 
frontal gyrus, posterior cingulate 
bilaterally, angular gyral bilaterally
- FA ↑: WM of the left subgenual 
anterior cingulate, pontine 
tegmental bilaterally and right 
middle/superior frontal gyri
ROI Clark et al.16 20 - 32 In relatives, FA↓:
Left inferior longitudinal fasciculus
Knochel et al.17 16 - 15 In relatives, FA↓:
Corpus callosum
Munoz Maniega et 
al.11
22 - 51 In relatives, FA↓:
Anterior limb of the internal capsule
Camchong et al.7 22 - 30 In relatives, FA↓:
Right genu of the CC
Knochel et al.10 18 - 22 In relatives, FA↓:
Commissural fibers, association 
fibers and the cingulum bundle
VBA, Voxel-based analysis; ROI, Regions-of-interest; FA, Fractional Anisotropy; ↓, decrease; ↑, 
increase; WM, white matter; CC, Corpus callosum
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At follow up, a significant lower whole-brain mean FA was found in both patients and 
siblings compared to controls, whereas the significant difference between patients 
and siblings from the baseline analysis was no longer apparent. The FA difference 
between sibling and controls at follow-up is in line with some of the previous cross-
sectional sibling studies. Considering the varying mean age-ranges (20-42 years) of 
siblings in the different studies, this may have influenced the FA outcomes and explain 
some of the inconsistencies in the literature. Based on the current findings and pre-
vious cross-sectional FA studies in siblings 5, the FA course over time in unaffected 
siblings of patients with a psychotic disorder can be described as: (i) a whole-brain 
mean FA similar to healthy controls and stable over time, (ii) a lower or equal mean 
FA compared to controls and an earlier-than-expected by age decline of FA over time, 
(iii) a lower mean FA compared to controls but stable over time (thus at a constantly 
lower level than controls).
The current results of WM alterations are indicative of an aberrant WM development 
curvature in siblings (whole-brain FA and regional) and patients (regional FA) and of 
a potential fronto-temporal (cingulum) WM intermediate phenotype. The alterations 
in the (right) cingulum bundle, an important white matter fibre tract of the limbic 
system, fit in the extensive literature on the this tract and will therefore be discussed 
in more detail below.
Cingulum bundle
Structural alterations in the cingulum in psychotic disorder
Due to the central role of the cingulum in emotional and cognitive processing (See Box 
1), microstructural WM alterations in this particular tract have been implicated in the 
pathogenesis of psychotic disorder. To date, numerous ROI imaging studies have been 
conducted in patient samples at different stages of the disease, assessing WM altera-
tions in the cingulate region. The evidence provided by over a dozen cross-sectional 
studies and one longitudinal study comparing patients with schizophrenia and healthy 
controls, show a consistent pattern of decreased left and right grey matter volume in 
the anterior cingulate gyrus 21, decreased FA in especially the (right) anterior part of 
the cingulum 22-25 and a greater decline in FA over a 4-year period in the left anterior 
cingulate gyrus in patients with a chronic psychotic disorder 26.
As stated in a qualitative review of structural neuroimaging findings in schizophrenia 
by Wheeler and Voineskos (2014), less equivocal are the findings in patients with a 
first psychotic episode. These findings reveal a more widespread pattern of WM ab-
normalities, with an equal number of studies (3) showing FA decreases and absence 
of FA differences in the cingulum 25. However, the study by Tang and colleagues (2010) 
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that reported significantly reduced FA in the right anterior cingulum in 38 adolescents 
with early-onset schizophrenia compared to healthy volunteers 27, was not included 
in this review.
Box 1: Role of the Cingulum
The cingulum bundle is the major WM tract, projecting from the cingulate gyrus to the 
entorhinal cortex, establishing the main communication pathway in the limbic system, 
connecting the cingulate gyrus with several other important brain regions, including 
the premotor, prefrontal and parietal cortices, thalamus, and hippocampus. Given the 
connection with the latter region, the cingulum is also associated with cognitive tasks as 
attention and memory. Thereby, it is part of the cingulate cortex, in particular the anterior 
cingulate cortex (ACC), which is primarily concerned with emotions and pain 31.
It has been proposed that FA reductions in the cingulate gyrus may be associated with 
(subclinical) psychotic symptoms. Indeed, in patients with schizophrenia a negative 
association was found between FA and impulsivity in the anterior cingulate 28, and 
between FA and PANSS positive scores in the posterior cingulum bundle (CB) bila-
terally 29. In addition, a trend positive association between positive symptom scores 
and FA in the left anterior cingulum in a small sample of recent onset patients with 
psychotic disorder 30 has been described.
Thus, white matter alterations in the cingulate region, including symptoms-associ-
ations, have been repeatedly reported in studies on diverse populations within the 
psychosis continuum.
Cingulum WM alteration as a potential intermediate phenotype
Various WM abnormalities in unaffected siblings have been proposed as WM en-
dophenotype, though not with a consistent pattern of involved neuroanatomical 
regions (see Table 1). The corpus callosum, however, is more frequently replicated 
and a potential candidate 5. The data presented in this thesis show an earlier than-
expected-by age FA decline in the right cingulum in siblings. Together with evidence 
from two other (cross-sectional) voxel-based 15 and ROI 10 studies, support for the 
cingulum as WM endophenotype candidate is available. It is known that siblings of 
patients with psychotic disorder may suffer from mild subclinical positive and disor-
ganized symptoms, reduced emotional expression, and social dysfunction 32. Studies 
examining WM alterations in unaffected relatives nevertheless did not find significant 
associations between FA and subclinical positive and negative symptoms 6, cognitive 
symptoms (sustained attention, executive functions and verbal memory 13, and social 
and global functioning or IQ 9. In contrast, a study by Knochel and colleagues (2012) 
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showed a negative association in healthy relatives between whole-brain FA and the 
severity of positive symptoms, a predisposition towards hallucinations and subjective 
cognitive dysfunction 10. Associations between subclinical symptoms in unaffected 
relatives and microstructural WM would have further strengthened the hypothesis 
of a white matter intermediate phenotype. However, detecting this may be compli-
cated due to the fact that anisotropy may need to reach a critical threshold before 
symptom-correlations become manifest.
Overall, based on the current findings and previous literature, the cingulum seems 
to fit the major criteria for a reliable candidate structural endophenotype, as brain 
alterations in this area: (1) have been associated with genetic risk variations (e.g. SNPs 
in the NRGN gene 33 and the ZNF804A gene 34), (2) are present in siblings of patients 
with a psychotic disorder at a higher rate than the general population 10, 15, (3) are 
present without clinical psychotic symptoms. The ‘ultimate’ intermediate phenotype 
likely comprises an integrative network of functionally interacting WM pathways 35. 
Therefore, future studies using advanced diffusion imaging techniques, combining 
(longitudinal) anatomical and functional measures of connectivity in large, clearly 
defined, samples of first-degree relatives and psychotic patients at different illness 
stages, should be conducted. Results of such studies are necessary to elucidate the 
possibility of a WM intermediate phenotype that may serve as a candidate marker for 
early and preclinical identification of subjects at risk or as a quantitative trait marker 
for future genetic studies.
The role of environmental exposures in microstructural 
white matter alteration
An interesting study by Chiang and colleagues (2011) showed how genetic influence 
on WM integrity can change over the first three decades of life in a large healthy 
twin-sample. WM heritability was associated with younger age (adolescence), male 
sex, higher IQ and higher SES, while FA was higher in adulthood. The suggestion was 
made that environmental influences, e.g. education, life experiences and diet, may 
increasingly determine brain fibre network development as one matures into adult-
hood 36. Studies assessing environmental risks in relation to WM integrity in patients 
with schizophrenia are scarce, let alone in genetic high-risk populations.
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Structural	Imaging	
	
In	!a#ents	)ith	!s,chosis	vs.	controls:	
•  Bilateral	ACG:	êGM	volume	
•  Anterior	part	Cingulum,	right	:	êFA		
•  ACG,	le4:	êΔFA	
	
In	siblings	vs.	controls:	
•  Cingulum,	right:	êΔFA	
•  CG,	bilateral:	êFA	
•  CB:	êFA			
	
Psycho>c	symptoms	
	
•  AC:	FA	<−>	Impulsivity	
•  Posterior	CB,	bilateral:		
						FA	<−>	PANSS	posi>ve	symptoms	
•  CB:	êFA	in	pa>ents	with	SCZ	with			
																																					delusions	of	control		
	
	
	
	
Environment	
	
•  Cingulum,	right:	ΔFA	<−>	Childhood	
trauma		
•  CB,	le4:	FA	<−>	Parental	verbal	abuse,	
childhood	trauma		
•  ACG:	GM	volume	<−>	Cannabis		use	
•  ACC,	le4:	CT	<−>	Cannabis		use	
	
	
	
	
	
	
	
	
	
Genes	
	
•  ACC,	le4:	êGM	volume	in	pa>ents	with	
SCZ	with	risk	T	allele	NRGN		
•  CG,	le4:	êFA	in	pa>ents	with	SCZ	with	risk	
variant	rs	1344706	of	ZNF804A	gene	
Fig. 1. Structural imaging fi ndings of grey and white matt er alterati ons in the cingulum associated 
with psychoti c symptoms, environmental exposures and geneti c risk variati ons
ACG, Anterior Cingulate Gyrus; ACC, Anterior Cingulate Cortex; AC, Anterior Cingulate; CG, 
Cingulate Gyrus; CB, Cingulum Bundle; GM, Grey Matt er; FA, Fracti onal Anisotropy; Δ, FA change 
over ti me; ↓, FA decrease; WM, white matt er; <−>, negati ve associati on; SCZ, schizophrenia; 
PANSS, Positi ve and Negati ve Syndrome Scale
Childhood trauma
The presented study in chapter 4 showed, for the fi rst ti me, that the extent of WM 
alterati ons is conditi onal on the level of developmental trauma exposure in pati ents 
with a psychoti c disorder. Especially pati ents exposed to high levels of childhood 
trauma showed a signifi cant mean FA decrease compared to siblings and controls. 
This fi nding was also observed in the longitudinal design: higher levels of childhood 
trauma were negati vely associated with white matt er connecti vity change during the 
course of the illness. This eff ect was not found in the siblings and controls, which may 
have been caused by the lower overall trauma load in these two groups in the present 
sample. On the other hand, maltreated siblings and controls, compared to pati ents, 
may diff er in their (pre-existi ng or adapti ve) neurobiological resilience and in their co-
ping styles, moderati ng trauma eff ects on WM integrity. Imaging studies investi gati ng 
resilience, especially in psychoti c disorder, are scarce, reporti ng on increased fi bre 
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density and connectivity in respectively the anterior corpus callosum and the dorsal 
anterior cingulate cortex as well as on trauma associated GM volume differences in 
regions known for their role in the stress-circuit (see Box 2) 37, 38. Interestingly, in a 
recent review it was suggested that neurobiological differences may exist between 
traumatized and non-traumatized individuals, independent of the severity or even 
presence of psychiatric symptomatology. Thus, there may exist separate ecopheno-
types with distinctive genetic, neurobiological and clinical characteristics 37, stressing 
the importance of the integration of environmental components in biological/imaging 
research.
Childhood trauma associated WM tract alterations
In the current study we examined whether higher childhood trauma exposure was 
associated to specific (stress-related) regions. A ROI analysis was performed using the 
four WM tracts (left PTR, right RPIC, right cingulum, and right PCR) that had revealed 
significant group differences in ΔFA, as described in Chapter 3.
In patients, higher childhood trauma was associated with FA decline over time in the 
right RPIC (which was not significantly different from controls, only from siblings) and 
the right cingulum (which was trend-significantly different from controls and signifi-
cantly different from siblings).
Box 2: Neuro-circuitry of Stress
The amygdala plays a central role, involved in encoding and consolidation of emotional 
memory of events and regulating parts of the fear response by activating the 
hypothalamic-pituitary-adrenal (HPA) axis, which will be activated during a traumatic 
event. The amygdala receives auditory, visual and somatosensory input from the temporal 
and anterior cingulate cortices and passes output to other subcortical structures like 
the hypothalamus via the stria terminalis. The hippocampus, important for declarative 
memory, also plays a regulating role in the HPA-axis activation, with the fornix as his 
major output fibre bundle 41. The retrolenticular part of the internal capsule, containing 
fibres from the optic system and the long temporo-occipital tracts in the sagittal stratum, 
including the inferior longitudinal fasciculus, also transferring visual signals 42, may play 
a role in a visual limbic pathway, subserving emotional, learning and memory functions 
related to visual intrusions of a traumatic event.
Interestingly, the significant finding in the cingulum concurs with one of the main 
findings of a recent systematic review (n=25 studies) on the relation of white matter 
integrity and childhood trauma in non-psychotic (predominantly PTSD) patient po-
pulations 39. Hence, suggesting a role of the cingulate area across disorders, possibly 
reflecting a common pathway to trauma-related alterations, not specific to a certain 
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psychiatric disorder. The two aforementioned WM tracts are both involved in the 
neuro-circuitry of stress, (inter) connecting key structures in the limbic system like 
the amygdala, hypothalamus, hippocampus and frontal structures (medial prefrontal 
cortex and anterior cingulate cortex) to the rest of the brain 40. Previous ROI studies of 
non-psychotic patients with PTSD showed trauma and abuse-associated FA decreases 
in the corpus callosum 39. Although at baseline decreased FA was found in the corpus 
callosum in patients with a psychotic disorder (chapter 2), this WM tract was not exa-
mined in relation to childhood trauma as in the longitudinal tract-specific ROI analysis 
there was no evidence for a significant FA change over time, nor for a group effect on 
ΔFA in the corpus callosum (chapter 3). 
Nevertheless, both the corpus callosum and the cingulum have previously been found 
to be affected in healthy populations with stress experiences and in subjects with a 
clinical phenotype, such as schizophrenia, bipolar disorder or autism 44.
In conclusion, a complicated interplay between traumatic impact and psychosis/
illness-related factors may be at hand causing an additive effect upon pre-onset 
microstructural WM changes in patients with psychotic disorder. Hypothetically, 
childhood trauma may lead to (chronic) stress and cingulum and corpus callosum 
alterations, which could contribute to the emergence or maintenance of psychiatric 
symptoms or syndromes, depending on the pre-existing (epi)genetic vulnerability. In 
turn, the symptom- or syndrome related stress may additionally and adversely impact 
these WM tracts.
Cannabis
Besides the effects of trauma, early cannabis use as a major biological trigger for a first 
psychotic episode has been the topic of the current thesis. Previously, studies have 
shown that adolescents who used cannabis had a two-fold risk of later developing schi-
zophrenia 45, 46. However, the specific effect that cannabis may have on white matter 
is still unclear. One hypothesis is that cannabis, binding on the cannabinoid receptor 
CB1 at oligodendrocytes, may induce apoptosis of the oligodendrocyte progenitors, 
thereby affecting white matter development 47. Evidence is however inconclusive. 
For example, reduced GM volume in the anterior cingulate gyrus 48 and widespread 
reduced cortical thickness (CT) 49, as well as no differences in brain morphology 50, 51 
have been documented in patients with schizophrenia using cannabis compared to 
non-users. Habets and colleagues (2010) examining the same study sample, found 
cannabis-use associated decreased CT in patients with psychotic disorder as well as 
their unaffected siblings 49. A longitudinal study showed additional cortical thinning in 
the left dorsolateral prefrontal cortex, left anterior cingulate cortex and left occipital 
lobe in cannabis using first episode patients compared to non-using patients with 
schizophrenia during a 5-year scan interval 52.
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Cannabis associated WM tract alterations
DTI studies investigating WM microstructure in cannabis using non-psychotic patients 
are scarce, and often confounded by other drug use. A recent systematic review 
by Baker and colleagues (2013) included 10 studies, measuring diffusion indices in 
adolescent (non-psychotic) substance abusers (mainly alcohol and cannabis) com-
pared to non-using controls. Microstructural WM alterations, generally a lower FA, 
were predominantly found in neocortical association pathways such as the superior 
longitudinal fasciculus and the corpus callosum in adolescent substance abusers 53. 
Most studies found cannabis associated FA decreases, although FA increases have 
been detected, as well as absence of (cannabis related) white matter integrity loss 54. 
This absence of effect was also seen in a longitudinal study with 41 mid-adolescent 
cannabis and alcohol abusers, showing higher diffusivity in the SLF associated with 
greater alcohol consumption, but not for cannabis use, after an 18-month follow-up 
55. However, Epstein & Kumra (2015) reported that larger cannabis exposure during an 
18 month scan interval predicted a greater FA decrease in the left inferior longitudinal 
fasciculus (ILF) in non-psychotic adolescents with a cannabis use disorder (n=19) 
compared to healthy adolescents (n=29) 56.
DTI studies investigating the effect of cannabis on WM integrity in patients with 
schizophrenia are even less available. The presented study in chapter 4 showed, in 
patients with psychotic disorder (but not siblings and controls), a whole-brain mean 
FA decline over a 3-year period associated with higher levels of cannabis exposure. 
The ROI analyses did not yield convincing evidence for regional WM alterations. The 
cross-sectional results at follow-up showed significant whole-brain mean FA decrease 
in the heavy cannabis using patients with a psychotic disorder as compared to siblings 
and controls. These findings of decreased FA concur with a cross-sectional study by 
James and colleagues (2011) that also showed FA decreases in brain stem, internal 
capsule, corona radiata, superior and inferior longitudinal fasciculus in cannabis using 
patients with psychotic disorder  compared to non-using patients 57. However, an ear-
lier study found increased directional coherence in the bilateral uncinate fasciculus, 
the anterior part of the internal capsule and the frontal white matter in patients with 
a recent-onset psychotic episode, who had started to use cannabis before the age 17, 
compared to healthy controls 58.
Thus, diffusion studies examining the association of cannabis with brain white matter 
have described a variety of WM tracts, small effect sizes and contradictory directions 
of effect. These conflicting results may be explained by methodological differences, 
in analytical approach (voxel-based morphometry vs. ROI), and in sample characteris-
tics. Differences in age of onset, disease stage (early onset, first-episode vs. subacute), 
symptom severity, as well as the age of onset (before and after age of 17), frequency 
of cannabis use, type/strength of cannabis and other drug use complicate the search 
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for the underlying etiology of WM abnormalities in cannabis using patients with psy-
chotic disorder. Nevertheless, from the findings in this thesis, one may hypothesize 
that cannabis exposure in a critical age-period may alter (accelerate) the normal 
trajectory of WM brain maturation in genetically vulnerable individuals. Interaction 
with illness-related factors may subsequently cause additional reduction in WM FA 
later in life. Whether this has clinical implications or influences long-term prognosis 
needs further investigation.
In conclusion, the patient-specific childhood trauma and cannabis associated FA de-
cline provide further evidence for the role of environmental factors in cerebral white 
matter alterations associated with psychotic disorder, possibly in interaction with 
illness-related factors. In theory, altered connectivity may be an epiphenomenon, 
the resultant of developmentally altered wiring and / or aberrant synaptic plasticity 
59. The findings from the present thesis comply with aberrant WM connectivity that 
may have existed from or even before the early stages of the illness as well as with 
WM changes over time in a later phase of the illness, and depending on the level of 
environmental exposures. These environmental risk factors, along with other poten-
tial disease related factors (e.g. antipsychotic medication, reduced physical activity, 
social deprivation, smoking) may have led to an exceedance of the resilience capacity, 
thereby inducing an additional compromising effect on WM trajectory upon genetic 
vulnerability.
Antipsychotic medication
There is an ongoing debate on the effects of antipsychotic (AP) medication on brain 
tissue. Although results from animal studies and in-vivo studies suggest a protective 
effect of antipsychotics as they may promote (re)myelination 60 and influence cell pro-
liferation by modulating brain growth factors and cellular morphology 61, there is also 
evidence for lower brain weight and volume associated with antipsychotic medication 
62. A recent review on the effect of AP medication on progressive brain changes in 
schizophrenia, based on 41 longitudinal structural imaging studies (1391 patients vs. 
1135 controls), concluded that with regard to CT, GM and WM volume, that results 
are still inconclusive 63.
Although it was not one of the primary targets of this thesis, the effect of AP medica-
tion on brain structure (fractional anisotropy) was investigated in the patient sample. 
The cross-sectional results in chapter 2 did not yield a significant association between 
cumulative lifetime AP exposure and FA. In the longitudinal analysis, presented in 
chapter 3, a close to significant negative association was found between lifetime AP 
use and whole-brain mean ΔFA, as well as a significant negative association between 
cumulative AP exposure over a 3-year interval and whole brain mean ΔFA over those 
3 years. Especially in patients with the highest level of AP exposure, compared to 
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controls, there was a significant decrease in FA over time that was not seen in the low 
and moderate AP exposure groups.
These results are in line with two other studies on this matter, showing FA decrease 
in the bilateral anterior cingulate gyrus and the right anterior corona radiata in first-
episode drug-naïve psychotic patients (n=35) after 6 weeks of AP treatment 64, and FA 
reductions in the parietal and occipital WM regions after 12 weeks of treatment with 
a second-generation antipsychotic in first-episode psychotic patients (n=35) 65. Four 
other studies showed opposite results: i) a positive association between amisulpride 
dosage and FA change in the right corticospinal tract in 28 first-episode psychotic 
patients after a 6-week follow-up 66, ii) a reduction in mean diffusivity within the right 
pyramidal tract, left temporal lobe, and cingulate gyrus after 28 days of antipsychotic 
use in 8 drug-free acutely psychotic patients who responded to the treatment 67, iii) 
FA increase in mainly the uncinate, cingulum and corpus callosum in first-episode 
psychotic patients (n=42) after 12 weeks of antipsychotic treatment, whereas FA also 
positively correlated with AP exposure 68 and iv) widespread FA increase after 12 
weeks on clozapine treatment in 16 patients with psychotic disorder 69.
In summary, half of these longitudinal DTI studies, using a pre-post treatment measu-
rement, found a short-term (4-12 weeks) positive effect (FA increase) of AP medica-
tion on WM integrity in first-episode patients with psychotic disorder. This could fit 
the hypothesis that dopamine D2 blockers may reduce neurotoxic glutamate levels 
70 or have pro-myelinating effects, boosting myelin repair and oligodendrocyte dif-
ferentiation 71. The other half of the studies, including the one presented in chapter 3 
and 4 with the longest between-scan interval (3 years), found FA reductions in various 
brain regions associated with (long term) AP exposure and a minor confounding effect 
of AP use on some of the interactions with environmental risk factors.
Overall, the evidence suggests that AP medication, like other environmental and 
illness-related factors, may contribute to microstructural WM alterations (increase 
and decrease),
The inconsistencies between the studies to date may have resulted from hete-
rogeneous patient samples and differences in illness duration, AP type (first and 
second generation antipsychotics), cumulative lifetime AP dose assessment, and DTI 
processing techniques. Longitudinal (short, medium and long-term) studies using 
advanced diffusion imaging techniques, such as ‘diffusion kurtosis imaging’ or ‘free 
water imaging’ to examine respectively tissue characterization and putative signs for 
neuro-inflammation in more detail 72, could help to further elucidate the impact of AP 
medication on neuronal (white matter) integrity.
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Methodological considerations & directions for future 
research
The present thesis provides important new insights on WM structure in patients 
with a psychotic disorder and their unaffected siblings. However, one has to keep in 
mind that MRI only yields an indirect measure of brain structure and that diffusion 
imaging is influenced by several non-anatomical factors, requiring complex imaging 
processing and analysing techniques. Jones & Cercignani (2010) have described the 
numerous steps in the processing pipeline with associated sources of bias that may 
lead to substantial errors 73. There are also various confounders (e.g. head motion, 
changes in body weight, blood lipid levels, nicotine use, exercise, cortisol levels), 
often not taken into account, resulting in inconclusive findings 74. Abovementioned 
sources of processing bias and confounders also apply to the DTI studies presented in 
this thesis, thus the results and conclusions in particular should be regarded with the 
necessary caution. Some (other) shortcomings of the presented studies in this thesis 
are discussed below with recommendations for future research.
DTI measure
The significance of the frequently reported cross-sectional and longitudinal findings 
of FA decreases is still unclear. FA is a rather non-specific indirect diffusion measure on 
‘neuronal integrity’, not necessarily referring to a damaging or degenerative process, 
when applied in other contexts (e.g. intelligence, creativity) 75. Secondary measures as 
radial diffusivity for the degree of myelination and axial diffusivity for axonal organiza-
tion are more informative on the etiology of WM alterations in terms of myelin loss or 
axonal incoherence but as yet, less frequently reported. Lately, as it is apparent that 
the structure of neural tissue may be too complex to comprehend through a single 
diffusion tensor, the focus has shifted to more advanced WM measures derived from 
‘Free Water Imaging (FWI)’ and the ‘Permeability Diffusivity Index (PDI) 72. Future 
studies examining WM integrity should implement these new diffusion methods to 
investigate the nature of the alterations in WM microstructure in more detail.
Sample size
Sample size and sample characteristics in neuroimaging studies are an important 
issue to take into account. Despite a relatively large sample size of the presented 
studies in this thesis compared to other diffusion studies, false positive results may 
be at hand. A recent study by Melicher and colleagues (2015) showed that detected 
regional FA differences strongly depend on the size of the studied sample. Studies 
with small samples are at risk for falsely suggesting WM abnormalities in certain re-
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gions 76. Therefore, a minimum sample size for diffusion imaging should be imposed, 
especially if subgroups or statistical interactions are analysed.
Sample characteristics
Diffusion imaging studies have reported WM abnormalities in a variety of brain 
regions 77 that have considerable overlap with regions detected in other psychiatric 
disorders, such as autism 78 and bipolar disorder 79. This may indicate that these 
WM alterations may not be disorder-specific, but rather reflecting trans-diagnostic 
symptom dimensions. The majority of the DTI studies included first-episode or chronic 
patients with psychotic disorder, based on DSM-IV criteria, not accounting for indivi-
dual fluctuations or presence of specific psychotic symptoms, subgroup-variations in 
illness severity, environmental (e.g. birth-complications, childhood trauma, cannabis 
use) and lifestyle factors (BMI, smoking, physical activity). More consistent findings 
are expected if future patient samples are compiled based on symptoms profiles and 
aforementioned patient-specific factors, and not solemnly on arbitrary (DSM-IV or 
DSM-5 based) diagnostic categories 80. The National Institute of Mental Health already 
adopted this approach defining the Research Domain Criteria (RDoC) framework, 
studying underlying functional constructs across different psychiatric disorders 81.
Combining DTI with resting state fMRI
The frequently reported microstructural WM alterations in patients with a psychotic 
disorder 82 correspond to various findings from functional connectivity studies, mainly 
showing alterations in the fronto-temporal brain region 83, the fronto-striatal circuit 
84 and the cingulo-opercular system, which is involved in interoception and salience 
processing 85. In order to investigate whether altered diffusivity (‘damage’) within 
relevant WM networks may be associated with abnormal neural activation (‘dysfunc-
tion’), studies combining diffusion imaging with resting-state functional MRI have 
been performed. The results showed associations between functional and structural 
connectivity 87, in particular for the cingulum tract, interconnecting the key regions of 
the default mode network 88. As resting-state scans were acquired and analysed of the 
current sample 86, it may be worthwhile to further explore such structure-functions 
associations in the near future.
Conclusion
This thesis investigated microstructural white matter alterations in patients with a 
psychotic disorder, unaffected siblings of patients with psychotic disorder and healthy 
controls. Patients showed: i) widespread reduced FA compared to siblings and con-
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trols, ii) a relatively stable whole brain FA over the 3-year follow-up period, and iii) a 
significant steeper decline in FA associated with higher levels of cannabis exposure 
and childhood trauma, as compared to siblings and controls. Siblings showed: i) no 
significant FA differences at baseline, ii) a significant mean FA decline (whole brain, in 
the right cingulum and in the left PTR) and a smaller FA increase in the right RPIC over 
the 3-year follow-up period, iii) a significant difference with controls in whole brain 
mean FA at follow-up, and iv) absence of cannabis and childhood trauma associated 
FA change over time. These findings partly comply with neurodevelopmental global 
and regional white matter alterations compromising connectivity in the early stage 
of psychotic disorder and in subjects at higher than average genetic risk. Genes and 
environment may not only influence neurodevelopmental processes, but also impact 
neuroplasticity later in life, possibly in interaction with illness-related factors.
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Summary
Cerebral vulnerability, characterized by altered neural communication between vari-
ous brain regions, is assumed to be one of the factors that contribute to the etiology of 
psychotic disorder. This structural dysconnectivity, possibly already occurring before 
illness-onset, may be caused by a complex interplay between genetic vulnerability 
and environmental risk factors during different stages of life. Diffusion tensor imaging 
(DTI) is a commonly applied method for investigating white matter (WM) structural 
connectivity in vivo. DTI is used in this thesis to investigate a potential WM interme-
diate phenotype for psychosis, to examine the course of WM development over time, 
and to explore the association between environmental stressors and WM change over 
time.
In chapter 1, a general introduction on the themes of this thesis, as well as the outline 
and aims of the thesis are described.
In chapter 2 a WM intermediate phenotype for psychosis is investigated. Although 
previous DTI studies in patients with a psychotic disorder have undisputedly shown a 
decrease in FA in fronto-temporal and fronto-occipital connections, a limited number 
of DTI studies, often with smaller sample sizes, have been performed on individuals at 
higher-than-average genetic risk for psychosis. In the current study, significantly lower 
mean FA in patients with a psychotic disorder compared to healthy controls was found 
throughout the brain, especially in the corpus callosum, forceps major and minor and 
several parts of the corona radiata. Intermediate values were found in healthy siblings 
with respect to patients and controls, yet no significant differences. Additional analy-
ses failed to show a clear association between microstructural WM and antipsychotic 
medication. No confounding effect of cannabis, and only a minor confounding effect 
of other drug use, on microstructural WM was found. Furthermore, it was examined 
whether the WM group differences were sex dependent. Results of this analysis 
showed that the group differences between patients and controls may be partly due 
to lower FA values in the female participants. In conclusion, the finding of widespread 
WM abnormalities in patients with a psychotic disorder may reflect illness-related 
brain pathology, not providing clear evidence for an intermediate phenotype.
In chapter 3, microstructural white matter is examined over time in patients with a 
psychotic disorder, unaffected siblings and controls, by analyses of diffusion scans 
that were acquired at two time-points with, on average, a three year interval. The pre-
sented longitudinal study showed a relatively stable whole-brain mean FA in patients 
with psychotic disorder, opposed to a significant FA decline in unaffected siblings with 
respect to controls. WM tract-specific analyses revealed more tracts with a decrease 
than an increase over time in both patients and siblings. In particular, a smaller mean 
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FA increase in the retrolenticular part of the internal capsule (RPIC), and a mean FA 
decrease in the posterior corona radiata (PCR) and the cingulum (all right-sided) was 
found in patients with respect to controls. In siblings, a significant smaller mean FA 
increase in the right RPIC and a mean FA decrease in the right cingulum was found 
with respect to controls. Thus, in contrast to baseline, at follow-up both patients and 
siblings had a lower whole-brain mean FA with respect to controls. The results provide 
evidence for a process of WM alterations in individuals with liability for psychotic 
disorder. Moreover, decreased FA in patients with respect to controls may stabilize 
over time, without (further) WM decline, at least over a certain period during the 
course of the illness.
Numerous epidemiological studies point to environmental risk factors such as ado-
lescent cannabis use and childhood trauma as the most common risk factors for 
psychotic disorder. In chapter 4 a cross-sectional as well as a longitudinal design was 
applied to examine the association between these environmental exposures and 
white matter alterations in patients with a psychotic disorder, their healthy siblings 
and a healthy control group. In contrast with the cross-sectional analysis at baseline, 
the follow-up analysis showed a significant negative association between cannabis use 
/ childhood trauma and FA in patients with a psychotic disorder. This concurred with 
the longitudinal analysis, in which a larger whole-brain mean FA decline over 3 years 
was associated with higher levels of cannabis exposure and higher levels of childhood 
trauma in patients with a psychotic disorder. This pattern of results was not seen in 
the siblings and controls. In additional analyses on specific WM tracts, it was found 
that the childhood trauma exposure was associated with white matter alteration in 
the right cingulum, a stress-processing related region. This is the first longitudinal 
DTI study showing that the extent of microstructural WM alterations in patients with 
a psychotic disorder (but not in siblings and controls) is conditional on the level of 
environmental risk exposure, suggesting interactions between the environment and 
illness-related factors.
In chapter 5, the findings presented in the previous chapters are discussed into more 
detail and integrated from a wider perspective. In addition, strengths and weaknesses 
of the presented studies in this thesis are highlighted, providing directions for future 
DTI studies.
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Cerebrale kwetsbaarheid, gekenmerkt door een veranderde neuronale communicatie 
tussen verschillende hersengebieden, wordt verondersteld een van de factoren te zijn 
die bijdraagt aan het ontstaan van een psychotische stoornis. Deze structurele discon-
nectiviteit, mogelijk al aanwezig voor aanvang van de aandoening, is het gevolg van 
een samenspel van genetische kwetsbaarheid en omgevingsrisicofactoren die zich 
door verschillende levensfasen heen voordoen. Diffusion Tensor Imaging (DTI) is een 
veelvuldig toegepaste in vivo methode om de mate van structurele connectiviteit van 
de witte stof te onderzoeken. DTI wordt in dit proefschrift toegepast om een  mogelijk 
witte stof endofenotype voor psychose op te sporen, witte stof ontwikkeling over 
een bepaalde tijdsinterval te volgen, en te onderzoeken of er een associatie is tussen 
omgevingsstressoren en witte stof afwijkingen over de tijd.
In hoofdstuk 1 wordt na een algemene inleiding over de thema’s in dit proefschrift, de 
opbouw en doelstellingen van het proefschrift besproken.
In hoofdstuk 2 wordt een witte stof endofenotype voor psychose onderzocht. Hoewel 
tal van DTI studies in patiënten met een psychotische stoornis een fractionele ani-
sotropie (FA) daling in fronto-temporale en fronto-occipitale witte stof verbindingen 
hebben aangetoond, zijn er slechts een beperkt aantal DTI studies uitgevoerd, vaak 
met kleinere aantallen proefpersonen, bij gezonde eerstegraads familieleden. In 
het gepresenteerde onderzoek worden er significant lagere FA waarden gevonden, 
verspreid in het brein, vooral in het corpus callosum, forceps major en minor en 
verschillende onderdelen van de corona radiata, bij patiënten met een psychotische 
stoornis vergeleken met gezonde controle personen. Intermediaire afwijkingen, wel-
iswaar zonder significante verschillen, worden gevonden bij gezonde broers/zussen, 
in vergelijking met de patiënten en de controles. Aanvullende analyses laten geen 
duidelijk associatie zien tussen witte stof veranderingen en antipsychotica gebruik 
en wordt er geen confounding effect van cannabis en slechts een gering confounding 
effect van andere (hard)drugs op de witte stof waargenomen.
Daarnaast is onderzocht of de gevonden groepsverschillen in witte stof afhankelijk 
zijn van geslacht. Resultaten laten zien dat het groepsverschil tussen controles en pa-
tiënten mogelijk deels wordt veroorzaakt door lagere FA waarden van de vrouwelijke 
proefpersonen. Kortom, de bevinding van wijdverspreide witte stof afwijkingen bij pa-
tiënten met een psychotische stoornis weerspiegelen mogelijke ziekte-gerelateerde 
breinpathologie, waarbij er geen duidelijke aanwijzingen zijn voor een endofenotype.
In hoofdstuk 3 wordt de witte stof ontwikkeling over een bepaalde tijdsinterval on-
derzocht bij patiënten met een psychotische stoornis, hun gezonde broers/zussen en 
een gezonde controlegroep. De gepresenteerde longitudinale studie toont over een 
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periode van ongeveer 3 jaar, een relatief stabiele FA van het gehele brein bij patiënten 
met een psychotische stoornis, in tegenstelling tot een significante FA daling bij de 
broers/zussen, vergeleken met de gezonde controle groep. Een analyse gericht op de 
individuele witte stof vezelbundels toont aan dat meer bundels een FA daling laten 
zien i.p.v. een stijging bij zowel patiënten als hun gezonde eerstegraads familieleden, 
vergeleken met de gezonde controle personen. Er wordt een significant kleinere FA 
stijging gevonden van het retrolenticulaire deel van de capsula interna (RPIC), en een 
significante FA daling van de corona radiata posterior en het cingulum (allen rechtszij-
dig) bij de patiënten vergeleken met de controles. Bij de gezonde broers/zussen wordt 
ook een significant kleinere FA stijging gevonden van de rechter RPIC en FA daling van 
het rechter cingulum, wederom vergeleken met gezonde controles. In tegenstelling 
tot bij de nulmeting (hoofdstuk 2), wordt nu bij de follow-up een lagere FA van het 
gehele brein gevonden bij zowel patiënten met een psychotische stoornis als hun 
broers/zussen, vergeleken met de controle groep. Dit resultaat duidt niet alleen op 
een verstoorde ontwikkeling van de witte stof bij mensen met een kwetsbaarheid 
voor een psychotische stoornis, maar suggereert ook een stabilisatie van witte stof 
achteruitgang na ontstaan van de psychotische stoornis, althans gedurende een 
bepaalde periode in het ziektebeloop.
Talrijke epidemiologische studies hebben aangetoond dat omgevingsrisicofactoren, 
zoals trauma in de kindertijd en cannabisgebruik in de adolescentie, veel voor-
komende risicofactoren voor psychose zijn. In hoofdstuk 4 wordt door middel van 
zowel een cross-sectionele als een longitudinale analyse, de associatie onderzocht 
tussen deze omgevingsstressoren en microstructurele witte stof veranderingen in 
patiënten met een psychotische stoornis, hun gezonde broers/zussen en een gezonde 
controle groep. In tegenstelling tot bij de nulmeting, worden bij de cross-sectionele 
vervolgmeting significante associaties gevonden tussen blootstelling aan cannabis / 
jeugdtrauma en FA bij patiënten met een psychotische stoornis. Dit komt overeen 
met de resultaten van de longitudinale analyse, waaruit blijkt dat een grotere FA 
daling in 3 jaar (gemiddeld over het gehele brein) is geassocieerd met een hogere 
blootstelling aan cannabis en jeugdtrauma bij patiënten met een psychotische stoor-
nis. Dit patroon is afwezig bij de eerstegraads familieleden van deze patiënten en 
gezonde controles. In een aanvullende analyse gericht op veranderingen in specifieke 
witte stof vezelbundels wordt gevonden dat blootstelling aan trauma in de kindertijd 
geassocieerd blijkt te zijn met witte stof afwijkingen in een gebied betrokken bij de 
stress-verwerking; het rechter cingulum. Dit is de eerste longitudinale DTI studie 
waaruit blijkt dat de omvang van de microstructurele witte stof veranderingen bij 
patiënten met een psychotische stoornis (maar niet bij broers/ zussen en controles) 
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afhankelijk is van de mate van blootstelling aan omgevingsrisicofactoren, en daarmee 
een interactie suggereren met omgeving en ziekte-gerelateerde factoren.
In hoofdstuk 5 worden de bevindingen uit de voorgaande hoofdstukken meer in 
detail besproken en geïntegreerd vanuit een breder perspectief. Daarnaast worden 
de sterke en zwakke punten van de gepresenteerde studies in dit proefschrift belicht, 
waarbij aangrijpingspunten voor toekomstig DTI studies worden benoemd.
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Psychotic disorders are one of the leading causes worldwide of long-term disability. It 
is a psychiatric syndrome consisting of perceptual, cognitive, emotional and behavi-
oural symptoms. The prevalence rate is relatively low (±3% for the broader psychosis 
spectrum) and remission can be achieved for the majority of the patients. However, 
a reasonable proportion of patients with a psychotic disorder experience persisting 
social and professional impairments in daily life. The cost for psychotic disorders is 
still enormous, estimated almost 94 billion euros in 2010 in Europe, although the ratio 
of societal cost per patient to 2015 gross domestic product per capita varies from 37% 
in Switzerland to 214% in the UK 1. Expenses are related to long-term unemployment, 
and high costs of chronic use of treatment and support. The etiology of the disease 
is still largely unknown and the current treatment is not curative, merely focused on 
attenuating the primary symptoms 2, 3.
Science: new diffusion parameters, replication and other 
environmental risk factors
The presented studies in this thesis yielded several insights on the course of white 
matter (WM) integrity in patients with a psychotic disorder and their genetically 
related healthy siblings. One of the studies of this thesis showed widespread cross-
sectional patient-control differences in fractional anisotropy (FA), while siblings of 
patients revealed intermediate FA values, although not significant from the control 
group. These findings teach us that these WM alterations may reflect illness, or 
treatment related effects rather than a genetic risk. Future studies examining WM 
integrity should implement new diffusion methods as ‘Free Water Imaging (FWI)’ and 
the ‘Permeability Diffusivity Index (PDI) to investigate the nature of these alterations 
in WM microstructure in more detail 4.
For the first time, a small, but statistically significant FA decline in the right cingulum 
over a 3-year time period was found in healthy siblings compared to controls. This 
earlier-than-expected by age WM decline in siblings without any (subclinical) psycho-
tic symptoms may point to an aberrant WM development curvature and a potential 
WM intermediate phenotype. Replication of these results is needed, preferably inclu-
ding siblings at different age stages to acquire a more complete WM age-trajectory of 
this higher-than-average risk group.
The WM trajectory in the 3-year timeframe in patients with a psychotic disorder was 
rather stable, but appeared conditional on the level of cannabis use, the degree of 
childhood trauma experiences and exposure to antipsychotic (AP) medication. These 
findings provide evidence for an early neurodevelopmental cause of WM alterations 
in the pathology of psychotic disorder with a potential influence of (early) environ-
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mental factors and AP medication on WM development later in life. It is worthwhile 
to examine other environmental risk factors for psychotic disorder, such as pre-or 
perinatal birth defects, urban upbringing, and social exclusion, in relation to WM 
structure. This may help us to identify children at a young age with an increased risk of 
developing a psychotic disorder. Medical, psychological as well as societal precautions 
can then be taken to minimize the risk for psychosis as much as possible.
Clinic: prevention, diagnostic and prognostic marker
Diffusion tensor imaging has, despite numerous pitfalls 5, proven to be a useful 
research tool for in vivo investigation of structural brain abnormalities in psychotic 
disorder. However, the above-mentioned findings are all based upon group diffe-
rences and are not applicable to the individual patient in daily clinical practice. The 
presented data in this thesis may entail however promising new insights for daily and 
future clinical practice.
Present tense
(i) Although a clear causal relation between cannabis and trauma associated WM 
alterations over time and long-term prognosis in patients with psychotic disorder has 
not been established, physicians as well as patients should be aware of the potential 
impact of these environmental factors on cerebral vulnerability. This should not lead 
to negativism and determinism but to realistic information on resiliency and plasti-
city, thereby contributing to empowerment of patients and preventing professional 
stigmatization.
(ii) Society must be informed about adolescent cannabis use and childhood trauma as 
risk factors for the development of psychotic symptoms and the potential adverse ef-
fect on long-term WM brain development. Prevention campaigns should warn young 
adolescents not to experiment with or use cannabis, at least until their brains are fully 
matured. Evidence-based treatment programs for cannabis addiction (e.g. motivatio-
nal interviewing) should be applied at an early phase in the treatment of first-episode 
patients with comorbid cannabis abuse.
(iii) Neighbours, primary school teachers, general practitioners and mental health 
workers should signal family problems at an earlier stage to prevent cases of childhood 
abuse. Youth services should be sufficiently funded to support dysfunctional families 
or placing children into foster families if necessary, to prevent potential childhood 
traumas.
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(near) Future
(iv) There is still a considerable diagnostic delay for the diagnosis of psychotic disorder, 
which has serious consequences for the patient and his recovery. Patients may drop 
out of school, alienate from their families and friends, become vulnerable for drug 
abuse, and have an increased suicide risk 3. This delay is partly the result of the fact 
that patients with a psychiatric syndrome are diagnosed by thorough anamnesis and 
that in the prodromal or pre-psychotic phase the main symptoms can be vague and 
non-specific. An objective biological (imaging) marker is still missing, but would be 
very useful for diagnostic purposes, classification, staging of the disease, or prediction 
of the outcome 6. The present thesis showed that longitudinal change in potential 
WM biomarkers might be relevant to further exploration, since the degree of expo-
sure to an environmental stressor as well as the level of exposure to antipsychotic 
medication revealed different slopes of FA decline over time in patients with psychotic 
disorder. However, more specific and reliable WM measures are warranted in view of 
the disadvantages of the common applied diffusion indices (see below). Combining 
the clinical presentation of a patient with fixed interval WM measurements of specific 
regional WM tracts may provide us with information on the (positive or negative) 
effects of medication or drug use and finally, a long-term prognosis of the disease. 
However, whether a negative or positive WM slope is associated with worsening or 
amelioration of symptoms or a worse or better long-term outcome has not yet been 
established and needs further investigation.
(v) Given the overlapping FA findings in a various psychiatric disorders and the fact that 
diffusion data appears to be highly sensitive to common artifacts 7, diffusion imaging 
falls short when applied for etiological, diagnostic and prognostic purposes in psychi-
atry. However, a network analysis in which the patients’ symptoms, his functional and 
structural brain abnormalities, and his predisposed and current environmental stres-
sors are combined in a mathematical algorithm, may be a more promising diagnostic 
tool in the near future 8, 9.
Summary
In conclusion, the presented results in this thesis have several implications, on a 
scientific level, as well as on clinical reasoning and intervention level. The longitudinal 
results on the WM course in healthy siblings and the childhood trauma and cannabis 
associated WM alterations in patients with a psychotic disorder warrant further repli-
cation. Understanding the timing and effect of environmental risk factors on neuronal 
brain matter is crucial, as well as the age-related trajectory of brain tissue. Whether 
it is static, worsens over time or ameliorates throughout a recovery process is essen-
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tial in the improvement of knowledge of psychosis outcome and for planning future 
therapeutic strategies. Therefore, these presented results should be disseminated 
through peer reviewed journals and presentations on national and international (schi-
zophrenia) conferences, and also made accessible to patients and family members.
Although the clinical implications of this work are hitherto limited, the presented 
results in this thesis may play a supporting role in the implementation of public 
prevention programs (through e.g. television, social media). The general public must 
be aware of the detrimental effects of childhood trauma exposure and adolescent 
cannabis use on the developing brain, resulting in an increased risk for psychiatric 
disorders.
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“Weet je … Ik vind het meestal gewoon leuk om dingen te maken die lekker klinken en lekker 
bekken zonder dat het ook maar iets om het lijf heeft. Weet je wel? Dat is al moeilijk genoeg. Ik 
doe er ook nooit langer dan twee dagen over. Als je er langer over doet dan twee dagen is het 
meestal gewoon shit, weet je wel. Het is geen relativiteitstheorie”.
(Quote van Barry Hay in ‘Donderweg – Mijn leven in 
de fast lane van de popmuziek’ van Jaap Boots)
Het schrijven van dit proefschrift heeft ietsje langer geduurd dan twee dagen. Dat is 
je vast niet ontgaan. Maar het gaat dan ook niet om iets ‘simpels’ als het schrijven van 
het ultieme popliedje. Toch zie ik dit proefschrift ook wel een beetje als een eerste 
EP. Ooit onbesuisd eraan begonnen met haperende techniek (lees: software) en veel 
ongepolijst materiaal dat nog erg bijgeschaafd moest worden door de co-writers. 
De teksten barsten waarschijnlijk nog van de schoonheidsfoutjes en een echt eigen 
‘geluid’ moet ik nog ontdekken, maar het (al niet meer) jeugdig enthousiasme en 
uithoudingsvermogen is er hopelijk uit af te lezen. Net zoals bij een EP is ook dit 
proefschrift slechts tot stand gekomen met veel hulp van belangrijke anderen. Dit 
productie- en schrijversteam, de band, techniek en uitzinnige  groupies wil ik graag in 
min of meer willekeurige volgorde bedanken.
Special thanks to: Jim, Machteld, Ed, Stijn, Petra, Sanne, Christine, Truda, Inge, Wolf-
gang, alle proefpersonen, Alard, Vincent, Ron, Siemens, FSL, Maarten, Frank, Rob, 
Tineke, Nienke, Apple, Cécile, Philippe, Charlie, Manon, BrainVoyager, Trees, Johan, 
Dennis, Marjan, Lies, Koen, Debora, Kim, Rob, Marcel, Peter, Robert, Chris, Ritsaert, 
Irene, Mariëlle, Bart, Ruud, Gunter, Uli, Inez, Lydia, Ballorig, Richard, Rikus, Therese, 
Jolanda, Ine, Richel, Marijntje, Frans, Carsten, Albert, Jacqueline, Carla, Baer, Jan, 
Frenk, Ivo, Heidi, Freesurfer, Monique, Huib, Carin, Ingrid, Ruud, Harrie, Aafje, Nanda, 
Nina, HIC-team, K-Rock, Mia, Els, Herman, Loek, Vlieland, Benjamin, Min, René, 
Mondriaan, Spotify, Thomas, Jan Willem, Arno, David, Ivar, Pierre, Germaine, pap, 
mam, broertje, Ruben, Milan en mijn liefje…
… muito obrigado a todos!
Bij voorbaat mijn excuses aan de mensen die ik had moeten bedanken, maar  vergeten 
ben in dit lijstje op te nemen. Oh, en die debuut LP laat nog even op zich wachten…
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